Medifirst Solutions 10-Q 22 May 17 2017 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2017	May 18, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	Medifirst Solutions, Inc.
Entity Central Index Key	1,522,704
Trading Symbol	MFST
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Mar. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q1
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		498,264,499

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Current Assets:
Cash	$ 101,768	$ 165,017
Inventory	25,430	14,023
Prepaid items		15,720
Total current assets	127,198	194,760
Property, Plant and Equipment, net	1,711	1,871
Other Assets
Security Deposit	650	650
Intangible Asset -License Agreement, net	127,502	137,502
Total other assets	128,152	138,152
Total Assets	257,061	334,783
Liabilities
Accounts payable and accrued expenses	83,572	75,368
Accrued expenses - officer's compensation	415,197	405,197
Due to related party	8,921	8,921
Loans payable - stockholders	16,630	10,555
Note Payable for license agreement	150,000	150,000
Convertible notes payable	178,628	391,653
Derivative Liabilities	504,823	144,792
Total current liabilities	1,357,771	1,186,486
Commitments & Contingencies (Note 8)
Stockholders' Equity:
Common stock, $0.0001 par value; 1,500,000,000 shares authorized, 390,395,684 and 225,847,976 shares issued and outstanding, respectively	39,041	22,586
Additional paid in capital	1,809,234	1,232,996
Accumulated deficit	(2,948,991)	(2,107,293)
Total Stockholders' Equity	(1,100,710)	(851,703)
Total Liabilities & Stockholders' Equity	257,061	334,783
Series A preferred stock
Stockholders' Equity:
Preferred stock	5	5
Series B convertible preferred stock
Stockholders' Equity:
Preferred stock	$ 1	$ 3

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2017	Dec. 31, 2016
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,500,000,000	1,500,000,000
Common stock, shares issued	390,395,684	225,847,976
Common stock, shares outstanding	390,395,684	225,847,976
Series A preferred stock
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	50,000	50,000
Preferred stock, shares outstanding	50,000	50,000
Series B convertible preferred stock
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	50,000	50,000
Preferred stock, shares issued	8,000	0
Preferred stock, shares outstanding	8,000	0

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Statements of Operations [Abstract]
Product sales, net	$ 9,995
Total Revenues	9,995
Cost of goods sold	353
Gross income	9,642
Expenses:
Officer's compensation	25,000	25,000
Advertising and promotion	19,797	1,623
Computer and internet	206	120
Consulting fees	189,300	20,798
Professional fees	124,265	24,560
Rent	3,822	2,071
Travel	6,505	260
Dues and subscriptions	1,083
Other	25,343	9,371
Total Expenses	395,321	83,803
Net loss from Operations before other income, expenses	(385,679)	(83,803)
Other income and (expense)
Interest expense	(91,034)	(191,815)
Interest income		1,167
Loss on extinguishment of debt
Change in fair value -derivatives	(364,985)	(60,163)
Net loss before provision for income tax	(841,698)	(334,614)
Provision for income taxes
Net Loss	$ (841,698)	$ (334,614)
Loss per common share - Basic and fully diluted	$ (0.003)	$ (0.009)
Weighted average number of shares outstanding - Basic and fully diluted	329,731,464	38,705,017

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)	Total	Common Stock	Preferred Class A	Preferred Class B	Additional Paid in Capital	Accumulated Deficit
Balance at Dec. 31, 2015	$ (655,911)	$ 3,510	$ 5		$ 310,183	$ (969,609)
Balance, shares at Dec. 31, 2015		35,101,750	50,000
Issuance of common shares upon partial conversion of note at $0.00275 per share	3,011	$ 110			2,901
Issuance of common shares upon partial conversion of note at $0.00275 per share, shares		1,095,036
Issuance of common shares upon partial conversion of note at $0.00275 per share	3,535	$ 129			3,406
Issuance of common shares upon partial conversion of note at $0.00275 per share, shares		1,285,560
Issuance of common shares upon partial conversion of note at $0.003355 per share	3,041	$ 91			2,950
Issuance of common shares upon partial conversion of note at $0.003355 per share, shares		906,533
Issuance of common shares upon partial conversion of note at $0.00275 per share	750	$ 150			600
Issuance of common shares upon partial conversion of note at $0.00275 per share, shares		1,500,000
Issuance of Series B Preferred shares as part consideration for license agreement	3			$ 3
Issuance of series B preferred shares as part consideration for license agreement, shares				25,000
Issuance of common shares upon conversion of 3,400 shares of Series B Preferred Stock	(1)	$ 170		$ (1)	(170)
Issuance of common shares upon conversion of 3,400 shares of Series B Preferred Stock, shares		1,700,000		(3,400)
Additional paid in capital from derivative liability on debt conversion	10,152				10,152
Issuance of Series B Preferred shares as payment for inventory	50,000			$ 1	49,999
Issuance of Series B Preferred shares as payment for inventory, shares				10,000
Issuance of common shares upon conversion of 3,400 shares of Series B Preferred Stock	0	$ 170		$ 0	(170)
Issuance of common shares upon conversion of 3,400 shares of Series B Preferred Stock, shares		1,700,000		(3,400)
Issuance of common shares upon partial conversion of note at $.0033 per share	5,230	$ 158			5,072
Issuance of common shares upon partial conversion of note at $.0033 per share, shares		1,584,873
Issuance of common shares upon partial conversion of note at $.0033 per share	7,240	$ 219			7,021
Issuance of common shares upon partial conversion of note at $.0033 per share, shares		2,194,200
Issuance of common shares upon partial conversion of note at $.0044 per share	8,800	$ 200			8,600
Issuance of common shares upon partial conversion of note at $.0044 per share, shares		2,000,000
Issuance of common shares upon conversion of 3,900 shares of Series B Preferred Stock	0	$ 195		$ 0	(195)
Issuance of common shares upon conversion of 3,900 shares of Series B Preferred Stock, shares		1,950,000		(3,900)
Issuance of common shares to extend due date of a note payable at par value per share	30	$ 30
Issuance of common shares to extend due date of a note payable at par value per share, shares		300,000
Issuance of Series B Preferred shares as consideration for trademark purchase	19,999			$ 0	19,999
Issuance of Series B Preferred shares as consideration for trademark purchase, shares				4,000
Issuance of common shares upon partial conversion of note at $.0029 per share	7,288	$ 250			7,038
Issuance of common shares upon partial conversion of note at $.0029 per share, shares		2,500,000
Issuance of common shares upon partial conversion of note at $.0038 per share	3,058	$ 78			2,980
Issuance of common shares upon partial conversion of note at $.0038 per share, shares		783,062
Issuance of common shares upon conversion of 2,200 shares of Series B Preferred Stock	0	$ 110		$ 0	(110)
Issuance of common shares upon conversion of 2,200 shares of Series B Preferred Stock, shares		1,100,000		(2,200)
Issuance of common shares upon partial conversion of note at $.0036 per share	2,800	$ 77			2,723
Issuance of common shares upon partial conversion of note at $.0036 per share, shares		768,026
Issuance of common shares upon partial conversion of note at $.0028 per share	2,400	$ 85			2,315
Issuance of common shares upon partial conversion of note at $.0028 per share, shares		853,643
Issuance of common shares for services $0.01 per share	5,000	$ 50			4,950
Issuance of common shares for services $0.01 per share, shares		500,000
Additional paid in capital from derivative liability on debt conversion	42,092				42,092
Issuance of common shares upon partial conversion of note at $.002915 per share	3,800	$ 136			3,664
Issuance of common shares upon partial conversion of note at $.002915 per share, shares		1,356,747
Issuance of common shares upon partial conversion of note at $..002915 per share	7,288	$ 250			7,038
Issuance of common shares upon partial conversion of note at $..002915 per share, shares		2,500,000
Issuance of common shares upon partial conversion of note at $.0029 per share	6,420	$ 221			6,199
Issuance of common shares upon partial conversion of note at $.0029 per share, shares		2,213,714
Issuance of common shares upon partial conversion of note at $..002915 per share	8,940	$ 319			8,621
Issuance of common shares upon partial conversion of note at $..002915 per share, shares		3,193,941
Issuance of common shares upon partial conversion of note at $..002915 per share	9,270	$ 318			8,952
Issuance of common shares upon partial conversion of note at $..002915 per shares, shares		3,180,000
Issuance of common shares upon partial conversion of note at $.0029 per share	8,688	$ 300			8,388
Issuance of common shares upon partial conversion of note at $.0029 per share, shares		2,995,816
Issuance of common shares upon partial conversion of note at $.002915 per share	9,375	$ 335			9,040
Issuance of common shares upon partial conversion of note at $.002915 per share, shares		3,352,874
Issuance of common shares upon partial conversion of note at $..002915 per share	3,480	$ 119			3,360
Issuance of common shares upon partial conversion of note at $..002915 per share, shares		1,194,500
Issuance of common shares upon partial conversion of note at $..00352 per share	11,235	$ 333			10,902
Issuance of common shares upon partial conversion of note at $..00352 per share, shares		3,333,073
Issuance of common shares upon partial conversion of note at $.0039 per share	10,450	$ 269			10,181
Issuance of common shares upon partial conversion of note at $.0039 per share, shares		2,693,624
Issuance of common shares upon partial conversion of note at $.003465 per share	10,000	$ 289			9,711
Issuance of common shares upon partial conversion of note at $.003465 per share, shares		2,886,003
Issuance of common shares upon partial conversion of note at $.0029 per share	6,000	$ 223			5,777
Issuance of common shares upon partial conversion of note at $.0029 per share, shares		2,226,772
Issuance of common shares upon conversion of note payable at $.0005 per share	1,200	$ 240			960
Issuance of common shares upon conversion of note payable at $.0005 per share, shares		2,400,000
Issuance of common shares for services $.0092 per share	36,800	$ 400			36,400
Issuance of common shares for services $.0092 per share, shares		4,000,000
Issuance of common shares for services $.0092 per share	27,600	$ 300			27,300
Issuance of common shares for services $.0092 per share, shares		3,000,000
Issuance of common shares for services $.0083 per share	16,600	$ 200			16,400
Issuance of common shares for services $.0083 per share, shares		2,000,000
Issuance of common shares for services $.00083 per share	16,600	$ 200			16,400
Issuance of common shares for services $.00083 per share, shares		2,000,000
Issuance of common shares for services $.0078 per share	3,900	$ 50			3,850
Issuance of common shares for services $.0078 per share, shares		500,000
Issuance of common shares for services $.0065 per share	13,000	$ 200			12,800
Issuance of common shares for services $.0065 per share, shares		2,000,000
Issuance of common shares upon conversion of note payable at $.001 per share	3,000	$ 300			2,700
Issuance of common shares upon conversion of note payable at $.001 per share, shares		3,000,000
Issuance of common shares upon conversion of note payable at $.0028 per share	7,248	$ 251			6,997
Issuance of common shares upon conversion of note payable at $.0028 per share, shares		2,516,666
Additional paid in capital from derivative liability on debt conversion	99,387				99,387
Issuance of common shares upon partial conversion of note at $.0025	12,500	$ 500			12,000
Issuance of common shares upon partial conversion of note at $.0025, shares		5,000,000
Issuance of common shares upon partial conversion of note at $.0033	12,500	$ 370			12,130
Issuance of common shares upon partial conversion of note at $.0033, shares		3,696,081
Issuance of common shares upon partial conversion of note at $.0022	12,500	$ 571			11,929
Issuance of common shares upon partial conversion of note at $.0022, shares		5,705,841
Issuance of common shares upon partial conversion of note at $.002	11,500	$ 575			10,925
Issuance of common shares upon partial conversion of note at $.002, shares		5,750,000
Issuance of common shares upon partial conversion of note at $.0018	9,557	$ 525			9,032
Issuance of common shares upon partial conversion of note at $.0018, shares		5,251,122
Issuance of common shares upon partial conversion of note at $.0015	10,000	$ 667			9,333
Issuance of common shares upon partial conversion of note at $.0015, shares		6,666,667
Issuance of common shares upon partial conversion of note at $.0016	10,000	$ 644			9,356
Issuance of common shares upon partial conversion of note at $.0016, shares		6,436,527
Issuance of common shares upon partial conversion of note at $.0017	11,022	$ 668			10,354
Issuance of common shares upon partial conversion of note at $.0017, shares		6,679,822
Issuance of common shares upon partial conversion of note at $.0015	12,000	$ 800			11,200
Issuance of common shares upon partial conversion of note at $.0015, shares		8,000,000
Issuance of common shares upon partial conversion of note at $.0017	13,127	$ 796			12,331
Issuance of common shares upon partial conversion of note at $.0017, shares		7,955,721
Issuance of common shares upon partial conversion of note at $.0016	10,000	$ 645			9,355
Issuance of common shares upon partial conversion of note at $.0016, shares		6,451,139
Issuance of common shares upon partial conversion of note at $.0012	4,000	$ 323			3,677
Issuance of common shares upon partial conversion of note at $.0012, shares		3,231,334
Issuance of common shares for services $.0052 per share	10,400	$ 200			10,200
Issuance of common shares for services $.0052 per share, shares		2,000,000
Issuance of common shares for services $.0045 per share	15,750	$ 350			15,400
Issuance of common shares for services $.0045 per share, shares		3,500,000
Issuance of common shares for services $.0054 per share	16,200	$ 300			15,900
Issuance of common shares for services $.0054 per share, shares		3,000,000
Issuance of common shares for services $.0035 per share	7,000	$ 200			6,800
Issuance of common shares for services $.0035 per share, shares		2,000,000
Issuance of common shares for services $.0035 per share	3,500	$ 100			3,400
Issuance of common shares for services $.0035 per share, shares		1,000,000
Issuance of common shares for services $.0036 per share	28,440	$ 790			27,650
Issuance of common shares for services $.0036 per share, shares		7,900,000
Issuance of common shares for services $.0052 per share	10,400	$ 200			10,200
Issuance of common shares for services $.0052 per share, shares		2,000,000
Issuance of common shares for services $.005 per share	20,000	$ 400			19,600
Issuance of common shares for services $.005 per share, shares		4,000,000
Issuance of common shares for services $.0036 per share	18,000	$ 500			17,500
Issuance of common shares for services $.0036 per share, shares		5,000,000
Issuance of common shares for services $.0032 per share	20,800	$ 650			20,150
Issuance of common shares for services $.0032 per share, shares		6,500,000
Issuance of common shares upon final conversion of note at $.0013	10,001	$ 777			9,224
Issuance of common shares upon final conversion of note at $.0013, shares		7,757,309
Additional paid in capital from derivative liability on debt conversion	155,150				155,150
Additional paid in capital from conversion of accrued interest on notes	2,836				2,836
Net loss	(1,137,684)					(1,137,684)
Balance at Dec. 31, 2016	(851,703)	$ 22,586	$ 5	$ 3	1,232,996	(2,107,293)
Balance, shares at Dec. 31, 2016		225,847,976	50,000	26,100
Issuance of common shares upon conversion of note at $.0014	12,955	$ 942			12,013
Issuance of common shares upon conversion of note at $.0014, shares		9,421,629
Issuance of common shares upon conversion of note at $.0014	14,054	$ 1,022			13,032
Issuance of common shares upon conversion of note at $.0014, shares		10,221,272
Issuance of common shares upon conversion of note at $.0005	2,470	$ 494			1,976
Issuance of common shares upon conversion of note at $.0005, shares		4,940,180
Issuance of common shares upon conversion of note at $.0001	500	$ 500
Issuance of common shares upon conversion of note at $.0001, shares		5,000,000
Issuance of common shares upon conversion of note at $.0014	32,298	$ 2,349			29,949
Issuance of common shares upon conversion of note at $.0014, shares		23,489,690
Issuance of common shares upon conversion of note at $.0001	600	$ 600
Issuance of common shares upon conversion of note at $.0001, shares		6,000,000
Issuance of common shares upon conversion of note at $.0001	600	$ 600
Issuance of common shares upon conversion of note at $.0001, shares		6,000,000
Issuance of common shares upon conversion of note at $.0014	32,298	$ 2,349			29,949
Issuance of common shares upon conversion of note at $.0014, shares		23,489,687
Issuance of common shares upon conversion of note at $.0001	500	$ 500
Issuance of common shares upon conversion of note at $.0001, shares		5,000,000
Issuance of common shares upon conversion of note at $.0028	52,072	$ 1,894			50,178
Issuance of common shares upon conversion of note at $.0028, shares		18,935,250
Issuance of common shares for services $.0028 per share	5,600	$ 200			5,400
Issuance of common shares for services $.0028 per share, shares		2,000,000
Issuance of common shares for services $.0054 per share	21,600	$ 400			21,200
Issuance of common shares for services $.0054 per share, shares		4,000,000
Issuance of common shares for services $.0054 per share	16,200	$ 300			15,900
Issuance of common shares for services $.0054 per share, shares		3,000,000
Issuance of common shares for services $.0060 per share	18,600	$ 310			18,290
Issuance of common shares for services $.0060 per share, shares		3,100,000
Issuance of common shares for services $.0066 per share	33,000	$ 500			32,500
Issuance of common shares for services $.0066 per share, shares		5,000,000
Issuance of common shares for services $.0057 per share	45,600	$ 800			44,800
Issuance of common shares for services $.0057 per share, shares		8,000,000
Issuance of common shares for services $.0094 per share	47,000	$ 500			46,500
Issuance of common shares for services $.0094 per share, shares		5,000,000
Issuance of common shares for services $.0094 per share	47,000	$ 500			46,500
Issuance of common shares for services $.0094 per share, shares		5,000,000
Issuance of common shares for services $.0063 per share	25,200	$ 400			24,800
Issuance of common shares for services $.0063 per share, shares		4,000,000
Issuance of common shares for services $.0052 per share	5,200	$ 100			5,100
Issuance of common shares for services $.0052 per share, shares		1,000,000
Issuance of common shares for services $.0034 per share	6,800	$ 200			6,600
Issuance of common shares for services $.0034 per share, shares		2,000,000
Issuance of common shares for services $.0052 per share	4,680	$ 90			4,590
Issuance of common shares for services $.0052 per share, shares		900,000
Issuance of common shares upon conversion of 18,100 shares of Series B Preferred Stock	0	$ 905		$ (2)	(903)
Issuance of common shares upon conversion of 18,100 shares of Series B Preferred Stock, shares		9,050,000		(18,100)
Additional paid in capital from derivative liability on debt conversion	171,439				171,439
Adjustment for note conversion	(3,576)				(3,576)
Net loss	(841,698)					(841,698)
Balance at Mar. 31, 2017	$ (1,100,710)	$ 39,042	$ 5	$ 1	$ 1,809,234	$ (2,948,991)
Balance, shares at Mar. 31, 2017		390,395,684	50,000	8,000

Consolidated Statement of Stoc6

Consolidated Statement of Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Issuance of common shares upon partial conversion of note, share price		$ 0.00275
Issuance of common shares upon partial conversion of note, share price one		0.00275
Issuance of common shares upon partial conversion of note, share price two		0.003355
Issuance of common shares upon partial conversion of note, share price three		0.00275
Issuance of common shares upon partial conversion of note, share price four		0.0033
Issuance of common shares upon partial conversion of note, share price five		0.0033
Issuance of common shares upon partial conversion of note, share price six		0.0044
Issuance of common shares upon partial conversion of note, share price seven		0.0029
Issuance of common shares upon partial conversion of note, share price eight		0.0038
Issuance of common shares upon partial conversion of note, share price nine		0.0036
Issuance of common shares upon partial conversion of note, share price ten		0.0028
Issuance of common shares for services , share price	$ 0.0028	0.01
Issuance of common shares upon partial conversion of note, share price eleven		0.002915
Issuance of common shares upon partial conversion of note, share price twelve		0.002915
Issuance of common shares upon partial conversion of note, share price thirteen		0.0029
Issuance of common shares upon partial conversion of note, share price fourteen		0.002915
Issuance of common shares upon partial conversion of note, share price fifteen		0.002915
Issuance of common shares upon partial conversion of note, share price sixteen		0.0029
Issuance of common shares upon partial conversion of note, share price seventeen		0.002915
Issuance of common shares upon partial conversion of note, share price eighteen		0.002915
Issuance of common shares upon partial conversion of note, share price nineteen		0.00352
Issuance of common shares upon partial conversion of note, share price twenty		0.0039
Issuance of common shares upon partial conversion of note, share price twenty one		0.003465
Issuance of common shares upon partial conversion of note, share price twenty two		0.0029
Issuance of common shares upon conversion of note payable, share price twenty three		0.0005
Issuance of common shares for services, share price one	0.0054	0.0092
Issuance of common shares for services, share price two	0.0054	0.0092
Issuance of common shares for services, share price three	0.0060	0.0083
Issuance of common shares for services, share price four	0.0066	0.00083
Issuance of common shares for services, share price five	0.0057	0.0078
Issuance of common shares for services, share price six	0.0094	0.0065
Issuance of common shares upon conversion of note payable, share price twenty four		0.001
Issuance of common shares upon conversion of note payable, share price twenty five		0.0028
Issuance of common shares upon partial conversion of note, share price twenty six		0.0025
Issuance of common shares upon partial conversion of note, share price twenty seven		0.0033
Issuance of common shares upon partial conversion of note, share price twenty eight		0.0022
Issuance of common shares upon partial conversion of note, share price twenty nine		0.002
Issuance of common shares upon conversion conversion of note, share price thirty		0.0018
Issuance of common shares upon conversion conversion of note, share price thirty one		0.0015
Issuance of common shares upon partial conversion of note, share price thirty two		0.0016
Issuance of common shares upon partial conversion of note, share price thirty three		0.0017
Issuance of common shares upon partial conversion of note, share price thirty four		0.0015
Issuance of common shares upon partial conversion of note, share price thirty five		0.0017
Issuance of common shares upon partial conversion of note, share price thirty six		0.0016
Issuance of common shares upon partial conversion of note, share price thirty seven		0.0012
Issuance of common shares for services, share price seven	0.0094	0.0052
Issuance of common shares for services, share price eight	0.0063	0.0045
Issuance of common shares for services, share price nine	0.0052	0.0054
Issuance of common shares for services, share price ten	0.0034	0.0035
Issuance of common shares for services, share price eleven	0.0052	0.0035
Issuance of common shares for services, share price twelve		0.0036
Issuance of common shares for services, share price thirteen		0.0052
Issuance of common shares for services, share price fourteen		0.005
Issuance of common shares for services, share price fifteen		0.0036
Issuance of common shares for services, share price sixteen		0.0032
Issuance of common shares upon final conversion of note, share price		$ 0.0013
Issuance of common shares upon conversion conversion of note, share price	0.0014
Issuance of common shares upon conversion conversion of note, share price one	0.0014
Issuance of common shares upon conversion conversion of note, share price two	0.0005
Issuance of common shares upon conversion conversion of note, share price three	0.0001
Issuance of common shares upon conversion conversion of note, share price four	0.0014
Issuance of common shares upon conversion conversion of note, share price five	0.0001
Issuance of common shares upon conversion conversion of note, share price six	0.0001
Issuance of common shares upon conversion conversion of note, share price seven	0.0014
Issuance of common shares upon conversion conversion of note, share price eight	0.0001
Issuance of common shares upon conversion conversion of note, share price nine	$ 0.0028
Series B Preferred Stock [Member]
Issuance of common shares upon conversion of Series B Preferred Stock		3,400
Issuance of common shares upon conversion of Series B Preferred Stock, one		3,400
Issuance of common shares upon conversion of Series B Preferred Stock, two		3,900
Issuance of common shares upon conversion of Series B Preferred Stock, three		2,200
Issuance of common shares upon conversion of Series B Preferred Stock, four	18,100

Consolidated Statement of Cash

Consolidated Statement of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net loss	$ (841,698)	$ (334,614)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation & amortization expense	10,160	1,596
Stock Based Compensation	276,480
Change in assets and liabilities
Accrued Interest Receivable		(1,167)
Accounts payable and accrued expenses	34,378	17,627
Loss on fair market value of derivatives	364,985
Amortization of debt discount & other financing costs	83,133	211,922
Stockholder's loan		(3,969)
Prepaid expenses	15,720
Inventory	(11,407)
Net cash used by operating activities	(68,249)	(108,605)
Cash flows from investing activities:
Purchase of equipment
Net cash used by investing activities
Cash flows from financing activities:
Repayment of bank overdraft
Proceeds from issuance of common stock
Contribution of additional paid in capital
Proceeds from stockholder loan	5,000
Repayment of stockholders' loan
Proceeds from sale of Convertible notes payable		155,000
Net cash provided by financing activities	5,000	155,000
Net increase (decrease) in cash	(63,249)	46,395
Cash at beginning of period	165,017	156,958
Cash at end of period	101,768	203,353
Cash paid during the period for:
Interest
Income taxes	750
Non-cash investing and financing activities:
Common stock issued for note interest and note conversions	316,211
Accounts Payable exchanged for promissory note	$ 15,000

Nature of Operations and Summar

Nature of Operations and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2017
Nature of Operations and Summary of Significant Accounting Policies [Abstract]
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Note 1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization Medifirst Solutions, Inc. (“MSI” or the “Company”) was incorporated in Nevada in November 2010. The Company has not generated significant sales to date. The Company intends to have a diverse product line of consumer products. Since inception, the Company has been engaged in business planning activities, including researching the industry, identifying target markets for the Company’s products, developing the Company’s models and financial forecasts, performing due diligence regarding potential geographic locations most suitable for establishing the Company’s offices and identifying future sources of capital. At the present time, the Company is building products and affiliations in and related to the cosmetic healthcare industry. In July 2016, Medifirst, in response to its Premarket Notification 510(k) submission for “The Time Machine” Series Laser, received clearance from the U.S. Food and Drug Administration (“FDA”) to market its infrared Time Machine TTML- 8102000 Laser Thermal Therapeutic Device.The Company is actively putting together a sales and distribution team to offer our lasers in the US market. Pursuant to a sale and purchase agreement dated August 19, 2015 between the Company and the Company’s president, the Company acquired 100% of the equity interests in Medical Lasers Manufacturer, Inc. (“MLM”) with the total purchase price of 20,000 shares of the Company’s common stock at $0.001 per share (or $20). The fair value of the acquired entity was $20. The transaction was considered as a business acquisition and accordingly the acquisition method of accounting has been applied. MLM had no assets at the date of the business combination. The Consolidated financial statements include the accounts of MSI and its only wholly owned subsidiary, MLM. All material intercompany balances and transactions have been eliminated in consolidation. The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional funding to operationalize the Company’s current technology. Basis of Presentation The unaudited interim consolidated financial statements include the accounts of Medifirst Solutions Inc. and its wholly owned subsidiary (Medical Laser Manufactures, Inc., (collectively referred to as the “Company”). All material intercompany balances and transactions have been eliminated in consolidation. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the consolidated financial position of the Company as of March 31, 2017, the consolidated results of its operations for the three-month periods ended March 31, 2016 and 2017, the consolidated change in stockholders’ equity for the three-month period ended March 31, 2017 and the consolidated cash flows for the three-month periods ended March 31, 2016 and 2017. The results of operations for the three-month period ended March 31, 2017 are not necessarily indicative of the operating results for the full year. These financial statements should be read in conjunction with the audited consolidated financial statements and related disclosures for the year ended December 31, 2016 included in the Company’s Annual Report on Form 10-K for the year then ended. Revenue Recognition In general, the Company records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured. The following policies reflect specific criteria for the various revenues streams of the Company: Revenue is recognized at the time the product is delivered or services are performed. Provision for sales returns are estimated based on the Company’s historical return experience. Revenue is presented net of returns. Accounts Receivable The Company extends credit to its customers in the normal course of business and performs ongoing credit evaluations of its customers, maintaining an allowance for potential credit losses. Accounts receivable is reported net of the allowance for doubtful accounts. The allowance is based on management’s estimate of the amount of receivables that will actually be collected. The Company has not recorded an allowance for doubtful accounts as of March 31, 2017 or December 31, 2016. Inventory Inventory consists of finished goods and is stated at the lower of cost (first-in, first-out) or market value. Finished goods inventory includes hand held laser devices and their carrying cases. Equipment Equipment, consisting of computer equipment, is stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets, of five years. Long-Lived Assets The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds the estimated future cash flows, an impairment loss will be recorded by the amount the carrying value exceeds the fair value of the asset. In August 2015, the Company’s wholly-owned subsidiary MLM, acquired a trademark for $20,000. Due to the uncertainty of future cash flows from the trademark, management has deemed it to be impaired and recorded an impairment expense of $20,000 in 2015. Intangible Asset- Licensing Agreement On March 8th 2016 (with an effective date of October 1, 2015), the company, through it’s sole wholly-owned subsidiary (“Licensee”), entered into a Product and Know-How License Agreement (“Agreement”) with a Florida Corporation (“Licensor”) which is owned by a related party - the son of the Company’s CEO. The license provides with respect to the Technology, Licensor hereby grants to Licensee an irrevocable, nontransferable, royalty-bearing license, with a right of sublicense (the “License”), throughout the Territory in the Field of Use, whether or not under the Licensed Patent, to: - use or submit or deliver the Technology and/or any Product to any regulatory body throughout the Territory for purposes of obtaining approval to make, Sell, o+A568ffer for Sale, import, export and distribute the Technology or Products; and - use or copy the Technology and/or any Product; and - market, make, have made, Sell, offer for Sale, import and distribute Products; and - sublicense the Technology; and - prepare, or have prepared on its behalf, modifications, enhancements and/or derivative works of the Technology. In connection with the license granted, Licensor hereby grants to Licensee a license to the Licensed Patents, whether now existing or hereafter acquired. The consideration for the licensing agreement consisted of the issuance of 25,000 Series B Preferred stock shares to the Licensor (at par) plus a $150,000 promissory note issued by the Company to the licensor. The promissory note is payable 18 months from the date of issuance and bears interest at the rate of 10% per annum. The last part of the consideration in this license agreement is the royalty payments which have not taken effect yet since they are based on sales for which the company has had only minimum thus far. The licensing agreement is for a ten year period effective from October 1, 2015. The cost of the licensing agreement is being amortized over it’s ten-year period and charged to income on a straight-line basis. Debt Issues Costs and Debt Discount The Company may pay debt issue costs, and record debt discounts in connection with raising funds through the issuance of convertible debt. These costs are amortized over the life of the debt to interest expense. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts are immediately expensed. Beginning in 2015, the Company adopted ASU 2015-03: Simplifying the Presentation of Debt Issuance Costs and has reflected the deferred financing costs as a direct reduction of the related debt (See table included in Note 5 to Consolidated Financial Statements). March 31, 2017 Original Issue Discount For certain convertible debt issued, the Company provides the debt holder with an original issue discount. The original issue discount is recorded to debt discount, reducing the face amount of the note and is amortized to interest expense over the life of the debt. Derivative Liabilities Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes. The Company assessed its securities for purposes of determining the proper accounting treatment and valuation as set forth in the Statement of Financial Accounting Standard ASC 820–10–35–37 Fair Value in Financial Instruments Accounting for Derivative Instruments and Hedging Activities In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments. Once the derivative liabilities are determined, they are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives. Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the condensed consolidated balance sheets and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Financial Instruments The carrying amounts reported in the balance sheets for cash, accounts receivable, accounts payable, and other accrued liabilities approximate their fair values. Segment Information The Company follows Accounting Standards Codification (“ASC”) 280, “Segment Reporting”. The Company currently operates in a single segment and will evaluate additional segment disclosure requirements as it expands its operations. Net Income (Loss) Per Common Share The Company calculates net income (loss) per share based on the authoritative guidance. Basic earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share is Income Taxes The Company utilizes the accrual method of accounting for income taxes. Under the accrual method, deferred tax assets and liabilities are determined based on the differences between the financial reporting basis and the tax basis of the assets and liabilities, and are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. An allowance against deferred tax assets is recognized, when it is more likely than not, that such tax benefits will not be realized. The Company recognizes the financial statement benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in an examination. For tax positions meeting a “more-likely-than-not” threshold, the amount recognized in the financial statements is the benefit expected to be realized upon settlement with the tax authority. For tax positions not meeting the threshold, no financial statement benefit is recognized. The Company recognizes interest and penalties, if any, related to uncertain tax positions in income tax expense. The Company did not have any unrecognized tax benefits as of March 31, 2017, and does not expect this to change significantly over the next 12 months. Stock-Based Compensation The Company accounts for equity instruments issued to employees in accordance with ASC 718, Compensation - Stock Compensation. ASC 718 requires all share-based compensation payments to be recognized in the financial statements based on the fair value on the issuance date. Equity instruments granted to non-employees are accounted for in accordance with ASC 505, Equity. The final measurement date for the fair value of equity instruments with performance criteria is the date that each performance commitment for such equity instrument is satisfied or there is a significant disincentive for non-performance. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At March 31, 2017 and December 31, 2016, the Company had cash equivalents of $101,768 and $165,017 respectively. Recent Pronouncements In May 2014, FASB and IASB issued a new joint revenue recognition standard that supersedes nearly all GAAP guidance on revenue recognition. The core principle of the standard is that revenue recognition should depict the transfer of goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The new standard is effective for the Company to annual reporting periods beginning after December 15, 2017 (that is, a public organization is required to apply the new revenue standard beginning in the first interim period within the year of adoption). Additionally, the Board decided to permit public organizations to adopt the new revenue standard early, but not before the original public organization effective date (that is, annual periods beginning after December 15, 2016). A public organization should apply the new revenue standard to all interim reporting periods within the year of adoption. The Company has evaluated the impact of this ASU on the consolidated financial statements and has determined, at this time, the ASU’s implementation would not have a material impact on revenue recognition. See below - Accounting Standards Update 2016-10 - Revenue from Contracts with Customers (Topic 606) Identifying Performance Obligations and Licensing. On January 05, 2016, the FASB completed its Classification and Measurement of Financial Instruments project by issuing ASU No. 2016-01, Financial Instruments—Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The new guidance improves certain aspects of recognition, measurement, presentation and disclosure of financial instruments. For public business entities, the new guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company does not believe the impact of its pending adoption of this ASU on the Company’s consolidated financial statements will be material. In November 2015, FASB issued ASU 2015-17 - Income Taxes (Topic 740) Balance Sheet Classification of Deferred Taxes which simplifies the presentation of deferred income taxes. For public business entities, the amendments in this Update are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company does not believe the impact of its pending adoption of this ASU on the Company’s consolidated financial statements will be material. In March 2016, the FASB issued Accounting Standards Update 2016-09 Compensation—Stock Compensation (Topic 718) Improvements to Employee Share-Based Payment Accounting. The Board is issuing this Update as part of its Simplification Initiative. The objective of the Simplification Initiative is to identify, evaluate, and improve areas of generally accepted accounting principles (GAAP) for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided to users of financial statements. The areas for simplification in this Update were identified through outreach for the Simplification Initiative, pre-agenda research for the Private Company Council, and the August 2014 Post-Implementation Review Report on FASB Statement No. 123(R), Share-Based Payment. The Company is currently evaluating the impact of this ASU on the consolidated financial statements. In April 2016, the FASB issued Accounting Standards Update 2016-10 - Revenue from Contracts with Customers (Topic 606) Identifying Performance Obligations and Licensing. The core principle of the guidance in Topic 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps: 1. Identify the contract(s) with a customer. 2. Identify the performance obligations in the contract. 3. Determine the transaction price. 4. Allocate the transaction price to the performance obligations in the contract. 5. Recognize revenue when (or as) the entity satisfies a performance obligation. The amendments in this Update do not change the core principle of the guidance in Topic 606. Rather, the amendments in this Update clarify the following two aspects of Topic 606: identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas. The Company is currently evaluating the impact of this ASU on the consolidated financial statements.

Property, Plant and Equipment (

Property, Plant and Equipment (Net)	3 Months Ended
	Mar. 31, 2017
Property, Plant and Equipment (Net) [Abstract]
PROPERTY, PLANT AND EQUIPMENT (NET)	Note 2. PROPERTY, PLANT AND EQUIPMENT (NET) Equipment is recorded at cost and consisted of the following at March 31, 2017 and December 31, 2016: March 31, 2017 December 31, Computer equipment $ 8,956 $ 8,956 Less: accumulated depreciation (7,245 ) (7,085 ) $ 1,711 $ 1,871 Depreciation expense was $159 and $346, for the three months ended March 31, 2017 and 2016 respectively.

Due to Related Party

Due to Related Party	3 Months Ended
	Mar. 31, 2017
Due to Related Party [Abstract]
DUE TO RELATED PARTY	Note 3. DUE TO RELATED PARTY The Company was indebted to a related party through common management in the amount of $8,921 at March 31, 2017 and December 31, 2016, respectively. The loan bears no interest and is payable on demand. See Note 10 for additional related party transactions.

Loans Payable - Stockholders

Loans Payable - Stockholders	3 Months Ended
	Mar. 31, 2017
Loans Payable - Stockholders/Convertible Notes Payable [Abstract]
LOANS PAYABLE - STOCKHOLDERS	Note 4. LOANS PAYABLE - STOCKHOLDERS During the periods ended March 31, 2017 and 2016 a stockholder of the Company advanced the Company $-0- and $-0- respectively. The loan has a balance of $16,630 at March 31, 2017 and a balance of $8,955 as of December 31, 2016. The loan bears no interest and is payable on demand. In December 2012, the Company issued a promissory note to a stockholder in the amount of $5,000 with interest at 10% per annum. Principal and interest were due and payable on June 2, 2013. In April 2014, the note was amended to provide the note holder with the option to convert the note to the Company’s common stock at $0.0001 per share. Subsequently, in 2014, in a private transactions, the note holder transferred $2,500 of note principal to third parties and the new holders converted their holdings into 2,500,000 shares of the Company’s common stock. During 2015, the original note holder transferred an additional $2,400 of note principal to third parties who converted their holdings into 2,400,000 shares of the Company’s common stock. At March 31, 2017 and December 31, 2016, the loan had balance was $100 and $100, respectively. At March 31, 2017 and December 31, 2016, the Company was indebted to a stockholder in the amount of $1,000 and $1,500, respectively. The loan has an interest rate of 26.7%. In February 2017 the note was sold to another investor and that noteholder converted $500 in principal into 5,000,000 shares of common stock. Principal and accrued interest were due and payable on January 1, 2014. In February 2016, the Company issued a promissory note to a stockholder in the amount of $7,000 with interest at the rate of 6% per annum. On September 6, 2016 the note holder converted the entire principal balance and accrued interest into common stock and therefore at March 31, 2017 there is no principal balance remaining on the note.

Convertible Notes Payable

Convertible Notes Payable	3 Months Ended
	Mar. 31, 2017
Loans Payable - Stockholders/Convertible Notes Payable [Abstract]
CONVERTIBLE NOTES PAYABLE	Note 5. CONVERTIBLE NOTES PAYABLE Note Payable-BS In March 2011, the Company issued $800 aggregate principal amount of 6% convertible notes due in January 2012. Interest on the notes accrue at the rate of 6% per annum and are payable when the notes mature. The notes matured prior to conversion but have not been repaid. Interest continues to accrue at the rate of 6% per annum. The holder of one of the notes converted $110 of note principal into 1,100,000 shares of common stock as follows: Date of Conversion Principal Amount Converted Conversion Rate Shares Received June 2013 $ 70 $ 0.0001 700,000 August 2013 $ 40 $ 0.0001 400,000 In August 2013, in a private transaction, the same note holder transferred $330 of the remaining note principal plus $55 in accrued interest to a third party. In August 2013, in a private transaction, the new note holder transferred $5 of the remaining note principal to a third party who then converted the note into 50,000 shares of common stock. In September 2013, the new note holder converted $100 of note principal into 1,000,000 shares of common stock. In September 2013, in a private transaction, the new note holder transferred $35 of the remaining note principal to a third party who then converted the note into 350,000 shares of common stock. In November and December 2013, the new note holder converted an additional $90 of note principal into 900,000 shares of common stock as follows: Date of Conversion Principal Amount Converted Conversion Rate Shares Received November 2013 $ 40 $ 0.0001 400,000 December 2013 $ 50 $ 0.0001 500,000 In March and April 2014, the new note holder converted an additional $90 of note principal into 900,000 shares of common stock as follows: Date of Conversion Principal Amount Converted Conversion Rate Shares Received March 2014 $ 50 $ 0.0001 500,000 April 2014 $ 40 $ 0.0001 400,000 Subsequent to these conversions there remains $125 in note principal outstanding at March 31, 2017. Note Payable-SF In July 2013, the holder of the second note converted $240 of note principal into 400,000 shares of the Company’s common stock at $0.0006 per share. At March 31, 2017 and December 31 2016, the note had a remaining principal balance of $60 and $60, respectively. At any time on or after the maturity date, the holders of the notes, have the option of converting any of the unpaid principal and interest into the Company’s common stock. The notes plus any accrued but unpaid interest are convertible at the rate of $0.0001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 39,000,529 shares at March 31, 2017 and 22,562,213 shares at December 31, 2016. Note Payable-RK In May 2012, the Company issued a $25,000 6% per annum note that matured in November 2012. In December 2012 the note was amended to be a convertible note. Interest on the note accrues interest at 6% per annum and is payable when the note matures. The holder of the $25,000 note had the option of converting it at any time prior to maturity. The note plus any accrued but unpaid interest were convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock. The holder of the note converted $1,010 of note principal into 1,010,000 shares of common stock as follows: Date of Conversion Principal Amount Converted Conversion Rate Shares Received December 2012 $ 150 $ 0.001 $ 150,000 January 2013 $ 660 $ 0.001 $ 660,000 March 2013 $ 200 $ 0.001 $ 200,000 In July 2013, the Company retired $14,000 of note principal in payment for consulting services provided to the note holder. In July 2013, the note holder converted $300 of note principal into 300,000 shares of the Company’s common stock. In July 2013, in a private transaction, the note holder transferred the remaining note principal balance of $9,690 to a third party (See Note Payable-NW Note Payable-NW After receiving the transfer of the principal balance of $9,690 in July 2013 in the private transaction noted in Note Payable-RK In October 2013, the note holder converted $400 of note principal into 400,000 shares of the Company’s common stock at $0.001 per share. In October 2014, the note holder converted $1,100 of note principal into 1,100,000 of the Company’s common stock.The note holder has the option of converting the balance at any time with the approval of the Board of Directors. The note plus any accrued but unpaid interest are convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 22,562,213 shares at December 31, 2016 and 3,506,665 shares at December 31, 2015. In August 2016, the note holder converted $3,000 of note principal into 3,000,000 shares of the Company’s common stock. At March 31, 2017 and December 31, 2016, the remaining principal balance on this portion of the note is $715 and $715 respectively. Note Payable-MC #1 In August 2013, the note holder/stockholder who received the $4,475 in principal from the aforementioned noteholder, converted $700 of note principal into 700,000 shares of the Company’s common stock at $0.001 per share. In October 2013, in a private transaction, this note holder transferred $1,000 of note principal to a third party of which $700 was converted into 700,000 shares in June 2014. In January 2017 the remaining $2,075 principal balance on this note was transfered to another investor who during the same period converted the entire remaining principal balance into 4,190,480 common shares. Note Payable-MC #2 In April 2015, the Company issued a $3,000 8% per annum note that matures in October 2015. The holder of the note has the right to convert the principal into shares of the Company’s common stock at any time 180 days after the closing date at $0.0001 per share. Interest on the note accrues interest at 8% per annum and is payable when the note matures. During January 2017, the current noteholder converted $1,100 in principal balance into 11,000,000 shares of common stock. During the same period, the current noteholder transfered $600 of the remaining principal balance to another investor who then converted the entire principal balance he received into 6,000,000 shares of common stock. There remains $1,300 in principal balance at March 31, 2017 with the current noteholder and $3,000 in principal balance at December 31, 2016. Convertible Note Payable-VV to LG (8%)#1 In July 2015, the Company issued a convertible note payable in the principal amount of $59,000. The note matured in March 2016 and bears interest at 8%. Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company’s common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date. Through a series of conversions during 2016, the note holder converted all of the entire note principal and accrued interest into common stock thereby leaving no principal balance remaining on the note at March 31, 2017 and December 31, 2016. Convertible Note Payable-VV (8%) #2 In August 2015, the Company issued a convertible note payable in the principal amount of $38,000. The note matured in March 2016 and bears interest at 8%. Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company’s common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date. Through a series of conversions during 2016, the note holder converted all of the entire note principal and accrued interest into common stock thereby leaving no principal balance remaining on the note at March 31,2017 and December 31, 2016. Convertible Note Payable-LGC(8%) On October 8, 2015, the Company issued a convertible note payable in the principal amount of $31,000 with an Original Issue Discount of $1,500. The note matures on October 8, 2016 and bears interest at 8%. The note holder has the right at any time to convert any part or all of the outstanding unpaid principal balance into shares of the Company’s common stock at the discounted rate of 58% of the lowest market trading price during the 20 days prior to and including the conversion date. Through a series of conversions during 2016, the note holder converted all of the entire note principal and accrued interest into common stock thereby leaving no principal balance remaining on the note at March 31, 2017 and December 31, 2016. Debenture Payable - (5%) B (Original $100K) In June 2015, the Company issued a convertible note payable in the principal amount of $100,000. The note matures in December 2015 and bears interest at 5%. Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company’s common stock at the discounted rate of 50% of the average of the three lowest market trading prices during the 3 days immediately preceding the conversion date. The remaining principal balance on the note at June 30, 2016 was $40,000 after a private sale of $60,000 in principal and deemed accrued interest on May 2, 2016 to another investor and the issuance of a replacement note by the Company - see below- Convertible Note Payable-SO-B (8%) (Original $60k) On September 27, 2016 the remaining $40,000 in principal balance and accrued interest on the note was sold in a private transaction to another investor and the Company issued a replacement note in the amount of $50,000. Both of the above noted transactions which took place on May 2, 2016 and September 27, 2016 respectively, resulted in a loss on the extinguishment of the original debt in the amount of $4,733 from deeming accrued interest in excess of actual accruals. This loss is reported in the statement of operations for the year ended December 31, 2016. Through a series of conversions during 2016, the note holder converted all of the entire note principal and accrued interest into common stock thereby leaving no principal balance remaining on the note at March 31, 2017 and December 31, 2016. As a result of the aforementioned transactions and conversions, there is no principal balance remaining on the original $100,000 note as of March 31, 2017 and December 31, 2016. Convertible Note Payable-SO-B (8%) (Original $60k) On May 2, 2016, the Company issued to an Investor a replacement redeemable convertible note in the principal amount of $60,000 (“the Replacement Note”). The Note, which matures on May 2, 2017, pays interest at the rate of 8% per annum. This Replacement Note partially replaces a note originally issued on June 12, 2015 in the principal amount of $100,000 The holder of the note is entitled, at its option beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company’s common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion. Any unamortized original issue discount and deferred financing costs from the original note was expensed upon replacement. The derivative discount and liability on the original note was appropriately accounted for upon replacement and a new derivative discount and liability for the replacement note appropriately recorded. Through a series of conversions during 2016, the note holder converted all of the entire note principal and accrued interest into common stock thereby leaving no principal balance remaining on the note at December 31, 2016. Convertible Note Payable-CB (5%) (Original $35k) On October 15, 2015 the Company issued a convertible note payable in the principal amount of $35,000 with an Original Issue Discount of $5,000. The note matures on October 15, 2016 and bears interest at 5%. The note holder has the right at any time on or after the day that is six months from October 15, 2015 to convert any part or all of the outstanding unpaid principal balance into shares of the Company’s common stock at the discounted rate of 55% of the lowest market trading prices during the 20 days prior to the conversion date. During the months of May, June and July 2016, the holder of the above $35,000 Note converted all of the principal to common stock thereby leaving no principal balance payable on the note as of March 31, 2017 and December 31, 2016. Convertible Note Payable-LGC (8%) On January 7 2016, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an accredited investor (the “Investor”) for the sale of convertible redeemable notes in aggregate principal amount of $251,803. On January 7, 2016, the Company and the Investor conducted the first closing under the Purchase Agreement, pursuant to which the Company issued to the Investor (i) a convertible redeemable note in principal amount of $105,000 containing an original issue discount of $20,000 (the “$105K Note”); and (ii) a convertible redeemable note in principal amount of $50,000 (the “$50K Note” and together with the $105K Note, the “Notes”). Under the Purchase Agreement, on March 15, 2016 and June 15, 2016, the Company and the Investor conducted additional closings for the sale and purchase of additional notes having the same terms as the Notes in principal amounts equal to $50,000 and $46, 803, respectively (see Convertible Notes Payable-LGC (8%) BEN Convertible Notes Payable-LGC (8%) BEN In consideration for the issuance of the $105K Note, on January 13, 2016, the Company received net proceeds (after deducting the original issue discount and legal fees) in the amount of $75,697. In consideration for the issuance of the $50K Note, the Investor issued to the Company a $50,000 fully-collateralized secured promissory note (the “Investor Note”), pursuant to which the Investor agreed to pay the Company $50,000 on or before April 30, 2016. The Notes, which are due on January 7, 2017, bear interest at the rate of 8% per annum. Subject to a beneficial ownership limitation equal to 9.99%, principal and interest on the Notes is convertible into shares of the Company’s common stock (“Common Stock”) at a conversion price equal to 55% of the lowest trading price of Common Stock during the 20 trading day period prior to conversion. In accordance with the terms of the Purchase Agreement, the investor and the Company closed on the two outstanding notes ($50,000 and $46,803) in May and June 2016. The Company received the cash funding. As of March 31, 2017 and December 31, 2016 the entire remaining principal balances of $50,000 and $46,803 respectively was outstanding. Convertible Notes Payable-SO (8%) On May 2, 2016, the Company issued to an Investor a convertible redeemable note in the principal amount of $57,750 (“the Note”). The Note, which matures on May 2, 2017, pays interest at the rate of 8% per annum. The note contains a 10% original issue discount. The holder of the note is entitled, at its option beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company’s common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion. During the quarter ended March 31, 2017 the noteholder converted $32,298 of the principle balance into 23,489,690 shares of common stock thereby leaving a principal balance of $25,452 on the note at March 31, 2017. The entire principal balance in the amount of $57,750 was outstanding on the note at December 31, 2016. Convertible Notes Payable-LG (9%) On October 11, 2016, the Company issued to an Investor a replacement convertible note in the principal amount of $50,000 (“the Replacement Note”). The Note, which matures on March 27, 2018, pays interest at the rate of 9% per annum. This Replacement Note partially replaces a note originally issued on June 12, 2015 in the principal amount of $100,000. During the quarter ended December 31, 2016 the noteholder converted the entire principal balance into shares of common stock thereby leaving $-0- principal balance remaining on the note as of March 31, 2017 and December 31, 2016. Convertible Notes Payable-BBCG (9%) On October 11, 2016, the Company issued to an Investor a convertible note in the principal amount of $157,895 (“the Note”). The Note, which matures on March 27, 2018, pays interest at the rate of 9% per annum. The note contains an original issue discount in the amount of $7,895. The holder of the note is entitled, at its option beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company’s common stock at the price equal to 57.5% of the lowest trading price for the twenty prior trading days including the date of conversion. The entire $157,895 in principal balance remains outstanding on the note as of March 31, 2017 and December 31, 2016. The Company’s convertible notes payable and the related derivative liabilities, derivative discount, deferred financing costs and original-issue discount are presented in the financial statements at March 31, 2017 as follows: Remaining Original Deferred Total 3/31/2017 Principal Issue Derivative Financing Convertible Derivative Debt Amount Discount Discount Costs Notes Payable Liability Note Payable - BS $ 125 $ 125 Note Payable - SF 60 60 Note Payable - SD 15,000 15,000 Note Payable - NW 715 715 Note Payable - MC #2 1,300 1,300 Convertible Note Payable - CB (5%) - - 1,358 Convertible Note Payable - LGC (8%) BEN 50,000 50,000 82,788 Convertible Note Payable - LGC (8%) BEN 46,803 46,803 76,566 Convertible Note Payable - LGC (9%) 50,000 50,000 81,797 Convertible Notes Payable- SO (8%) 25,452 (446 ) (6,893 ) (410 ) 17,703 41,481 Convertible Notes Payable- BBCG (9%) 157,895 (5,234 ) (155,738 ) (3,077 ) 220,833 $ 347,350 $ (5,680 ) $ (162,631 ) $ (410 ) $ 178,628 $ 504,823 As of March 31, 2017, the convertible notes payable can be converted into approximately 82,730,976 shares of common stock.

Derivatives and Fair Value Inst

Derivatives and Fair Value Instruments	3 Months Ended
	Mar. 31, 2017
Derivatives and Fair Value Instruments [Abstract]
DERIVATIVES AND FAIR VALUE INSTRUMENTS	Note 6. DERIVATIVES AND FAIR VALUE INSTRUMENTS The Company applied paragraph 815-10-05-4 of the FASB Accounting Standards Codification to the 5% Convertible Notes Payable issued June 12th 2015 and the 8% Convertible Note payable issued June 25th 2015 and for the 8% Convertible Notes Payable issued January 7, 2016 and March 7, 2016 and the 9% Convertible Note payable issued October 1, 2016. Based on the guidance in paragraph 815-10-05-4 of the FASB Accounting Standards Codification the Company concluded these instruments were required to be accounted for as derivatives on issuance date. The Company records the fair value of the Convertible Notes Payable and certain warrants that are classified as derivatives on issuance date and the fair value changes on each reporting date reflected in the consolidated statements of operations as “Gain (loss) on derivative liabilities.” These derivative instruments are not designated as hedging instruments under paragraph 815-10-05-4 of the FASB Accounting Standards Codification and are disclosed on the balance sheet under Derivative Liabilities. The Company follows paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35- 37”) to measure the fair value of its financial instruments and paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level Pricing inputs that are generally observable inputs and not corroborated by market data. Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepayments and other current assets, accounts payable, and accrued expenses, approximate their fair values because of the short maturity of these instruments. The Company’s Level 3 financial liabilities consist of the 5% Convertible Notes Payable issued June 12th 2015 and the 8% Convertible Note payable issued June 25th 2015 and for the 8% Convertible Notes Payable issued January 7, 2016 and March 7, 2016 and the 9% Convertible Note payable issued October 1, 2016, for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. We have valued the automatic conditional conversion, re-pricing/down-round, change of control; default and follow-on offering provisions using a lattice model, with the assistance of a valuation consultant, for which management understands the methodologies. These models incorporate transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of issuance and December 31, 2016. The primary assumptions include: projected annual volatility of 98%-223%; the follow-on securities purchase option; the conversion feature as a percentage of Market; automatic/conditional conversions; market price trigger events. As of March 31, 2017 the Company’s derivative financial instruments included: 1) Embedded derivatives associated with certain of the Company’s unsecured convertible notes payable. The Company’s 5 % convertible notes payable and 8% convertible notes payable and 9% convertible note payable issued to unrelated investors is a hybrid instrument, which warrants separate accounting as a derivative instrument. The embedded derivative feature has been bifurcated from the debt host contract, referred to as the Derivative Liability, which resulted in a reduction of the initial carrying amount (as unamortized discount) of the Convertible Notes Payable. The unamortized discount is amortized to interest expense using the effective interest method over the life of the Notes. The embedded derivative feature includes the conversion feature within the notes and an early redemption option. The compound embedded derivatives within the convertible notes have been recorded at fair value at the date of issuance; and are marked-to-market each reporting period with changes in fair value recorded to the Company’s statement of operations as Change in fair value of derivative liabilities. The 5% Convertible Note Payable and the 8% Convertible Notes Payable and the 9% convertible note payable are valued at March 31, 2017. The following assumptions were used for the valuation of the embedded derivative: - The stock price of $0.0032 increased to $0.0091 in this period (basis for the variable conversion price) would fluctuate with the Company projected volatility; - An event of default for the Convertible Note would occur 0% of the time, increasing 1.00% per month to a maximum of 5.0%; - Alternative financing for the Convertible Note would be initially available to redeem the note 0% of the time and increase monthly by 1% to a maximum of 10%; - Capital raising events (a single financing at 1 month from the valuation date) are a factor for the VV to LG Convertible Note. The full reset events projected to occur based on future stock issuance (single event) resulting in a reset exercise price. - The monthly trading volume would average $262,255 and would increase at 5% per month; ownership limits conversion across LG’s 6 notes based on 4.99% with shares outstanding increasing monthly by 1%. - The variable conversion price of 50% to 58% over 3 to 20 trading days would have effective rates of 35.76% to 49.73%; - The Note Holders would automatically convert the notes early (and not hold to maturity) with variable conversion prices and full ratchet resets if the registration was effective and not in default; - The projected annual volatility for each valuation period was based on the historical volatility of the company: 12/31/2016 154% 1/23/2017 152% 1/10/2017 159% 3/6/2017 165% 1/17/2017 149% 3/26/2017 168% 1/19/2017 171% 3/31/2017 174% The foregoing assumptions are reviewed quarterly and are subject to change based primarily on management’s assessment of the probability of the events described occurring. Accordingly, changes to these assessments could materially affect the valuation. The Company’s derivative liabilities on convertible notes payable are presented at market value in the financial statements at March 31, 2017 as follows: Convertible Note Derivative Treatment Date Maturity Date Principal Note Original Derivative Valuation Derivative Valuation December 31, 2017 Quarter Ended March 31, 2017 Issuances Quarter Ended March 31, 2017 Conversions Quarter Ended March 31, 2017 Mark-to- Market Derivative Valuation March 31, 2017 8% Convertible Note Payable- issued 5/2/2016 10/1/2016 5/2/2017 $ 57,750 $ 58,355 $ 58,355 $ (34,680 ) $ 17,806 $ 41,481 5 % Convertible Note- Payable - issued 6/12/2015 4/12/2016 1/7/2017 35,863 37,827 918 440 $ 1,358 9% Convertible Notes Payable- issued 10/01/2016 3/26/2017 3/27/2018 157,895 56,956 162,463 58,370 $ 220,833 8% Convertible Notes Payable- issued January 7, 2016 1/7/2016 1/7/2017 105,000 87,287 21,395 (136,759 ) 115,364 $ - 8% Convertible Notes Payable- issued January 7, 2016 1/7/2016 1/7/2017 50,000 15,803 15,803 66,985 $ 82,788 8% Convertible Notes Payable- issued March 7, 2016 3/7/2016 3/7/2017 50,000 87,538 36,449 45,348 $ 81,797 8% Convertible Notes Payable- issued March 7, 2016 3/7/2016 1/7/2017 46,803 82,115 15,894 60,672 $ 76,566 $ 503,311 $ 425,881 $ 148,814 $ 162,463 $ (171,439 ) $ 364,985 $ 504,823 The Company’s total mark-to-market fair value adjustment ((income)/expense) for the quarter ended March, 2017 amounted to $364,985.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2017
Stockholders' Equity [Abstract]
STOCKHOLDERS' EQUITY	Note 7. STOCKHOLDERS’ EQUITY The Company has authorized 1,500,000,000 shares of common stock with a par value of $0.0001 per share. There were 390,395,684 and 225,847,976 shares of common stock issued and outstanding at March 31, 2017 and December 31, 2015, respectively. The Company has authorized 1,000,000 shares of Series A preferred stock with a par value of $0.0001 per share. At December 31, 2016 and December 31, 2015, 50,000 shares of Series A preferred stock were issued and outstanding. The preferred stock has preferential voting rights of 100 votes per outstanding share. The Company has authorized 50,000 shares of Series B convertible preferred stock with a par value of $0.0001 per share. At December 31, 2016 there were 39,000 shares issued of which 12,900 shares of Series B preferred were converted into common stock in accordance with the terms of the Series B Preferred stock. Therefore; there were 26,100 shares outstanding at December 31, 2016. The Series B preferred stock has no voting rights. During the quarter ended March 31, 2017, 18,100 shares of Series B preferred shares were converted into common stock in accordance with the terms of the Series B preferred stock. As of result there were 8,000 shares of Series B preferred shares outstanding at March 31, 2017. The holders of the Series B convertible preferred stock have the right to convert the same into Common Stock of the Corporation at the ratio of one (1) share of Series B Convertible Preferred for five hundred (500) shares of Common Stock. During the quarter ended March 31, 2016, the Company issued an aggregate 4,787,129 shares of common stock at prices ranging from $0.00275 to $0.003355 per share as partial conversion of notes. During the quarter ended March 31, 2016, the Company issued 1,700,000 shares of common stock upon conversion of 3,400 shares of Series B preferred stock. During the quarter ended March 31, 2016, the Company issued 10,000 shares of Series B Preferred stock in settlement of the $50,000 liability to a related party for the purchase of inventory. During the quarter ended June 30, 2016, the Company issued an aggregate 10,683,804 shares of common stock at prices ranging from $0.0028 to $0.0044 per share as partial conversion of notes. During the quarter ended June 30, 2016 the Company amended a Convertible Debenture originally issued June 12, 2015. The Company issued 300,000 shares to the debenture holder for the main purpose of extending the maturity date to one year from the date of the amendment. During the quarter ended June 30, 2016, the Company issued 1,950,000 shares of common stock upon conversion of 3,900 shares of Series B preferred stock. During the quarter ended June 30, 2016, the Company issued 1,100,000 shares of common stock upon conversion of 2,200 shares of Series B preferred stock. During the quarter ended June 30, 2016, the Company issued 1,700,000 shares of common stock upon conversion of 3,400 shares of Series B preferred stock. During the quarter ended June 30, 2016, the Company issued 4,000 shares of Series B Preferred stock in settlement of the $20,000 liability to a related party for the purchase of a trademark. On April 15, 2016 the Company entered into a Business Consulting Agreement with a Michigan limited liability company (“Consultant”). The agreement provides for the Company retaining the Consultant for 125 days for general business and product development services. The Consultant shall be paid $750 per month in cash and 500,000 shares of common stock of the Company valued at $5,000 as of the effective date and another 500,000 common shares upon determination of the Company in its sole and absolute discretion. During the quarter ended June 30, 2016 pursuant to the Business Consulting Agreement, the Company issued 500,000 shares of common stock at $0.01 per share for services provided to the Company. During the quarter ended September 30, 2016, the Company issued an aggregate 39,043,730 shares of common stock at prices ranging from $0.0001 to $0.0092 per share as partial conversion of notes. During the quarter ended September 30, 2016, the Company issued 4,000,000 shares of common stock at $0.0092 per share for services provided to the Company. During the quarter ended September 30, 2016, the Company issued an aggregate 13,500,000 shares of common stock at prices ranging from $0.0001 to $0.0092 per share for services provided to the Company. During the quarter ended December 31, 2016, the Company issued an aggregate 78,581,563 shares of common stock at prices ranging from $0.0012 to $0.0054 per share as partial conversion of notes. During the quarter ended December 31, 2016, the Company issued an aggregate 36,900,000 shares of common stock at prices ranging from $0.0012 to $0.0054 per share for services provided to the Company. During the quarter ended March 31, 2017, the Company issued an aggregate 43,000,000 shares of common stock at prices ranging from $0.0028 to $0.0094 per share for services provided to the Company. During the quarter ended March 31, 2017, the Company issued an aggregate 112,497,708 shares of common stock at prices ranging from $0.0001 to $0.0028 per share as partial conversion of notes. During the quarter ended March 31, 2017, the Company issued an aggregate 9,050,000 shares of common stock for conversion of 18,100 shares of Preferred Series B stock.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2017
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	Note 8. COMMITMENTS AND CONTINGENCIES The Company currently has three office locations. It rents offices on a month-to-month basis from the Company’s President and stockholder for $525 per month which amounted to $1,575 for the quarter-ended March 31, 2017. The Company also has ready-to-go office space available to be used for meetings etc. at a nominal cost of approximately $100 per month with no commitment. The cost of this space for the quarter-ended March 31, 2017 was $297. On September 12th 2016 the Company entered into a commercial lease agreement for office premises at a cost of $650 per month for a one-year term with the option to renew for one extended term of three years. The cost of this space for the quarter ended March 31, 2017 was $1,950. Total rent expense for the quarter ended March 31, 2017 and 2016, totaled $3,822 and $2,071. The Company has agreements with consultants for ongoing services to be rendered with the following commitments: Commitment Term Consultant - FDA requirements and compliance $2,000 per month 12 Months Consultant - capital formation and market services Various equity percentage issuances of restricted stock for fundings 6 Months Consultant - tradeshow attendance, strategy and collaboration, coordination regarding FDA compliance, manufacturing operations, sales and marketing, other related services $10,000 per month (payable quarterly in cash or common stock from the 2016 Equity Incentive Plan) 12 Months

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2017
Income Taxes [Abstract]
INCOME TAXES	Note 9. INCOME TAXES The Company’s deferred tax asset consists primarily of carryforward net operating losses (NOLs). The Company believes that, at this time, it is more likely than not that the benefit of the NOLs will not be realized and has therefore recorded a full valuation allowance. The income tax benefit differs from the amount computed by applying the statutory federal and state income tax rates to the loss before income taxes. The sources and tax effects of the differences are as follows: December 31, December 31, Statutory federal income tax rate 34 % 34 % State income taxes, net of federal taxes 9 % 9 % Valuation allowance (43 )% (43 )% Effective income tax rate 0 % 0 % As of December 31, 2016, the Company has a net operating loss carryforward of approximately $1,125,667 to reduce future federal taxable income which begins to expire in the year 2030. The Company is also subject to corporate taxes in the State of New Jersey which has similar net operating loss carryover provisions which start to expire in the year 2030. The Company currently has no federal or state tax examinations in progress, nor has it had any federal or state examinations since its inception. All of the Company’s open tax years beginning in tax year 2013 are subject to federal and state tax examinations.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2017
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	Note 10. RELATED PARTY TRANSACTIONS In August 2015, the Company acquired 100% of the issued and outstanding common stock of Medical Lasers Manufacturer, Inc. (“MLM”) from a stockholder and officer of the Company for 20,000 common shares which were valued at $0.001 per share. All intercompany transactions were eliminated during consolidation. As more fully described in Note 3 to the Consolidated Financial Statements, the Company owed the following amounts to related parties as of the following: March 31, December 31, 2017 2016 Due to Related Party $ 8,921 $ 8,921 Due to officer/stockholder 16,630 10,555 Due to other stockholders 17,200 5,975 Total Related Party Obligations $ 42,751 $ 25,451 The company has entered into an employment agreement with its Chief Executive Officer (CEO) for the five year period beginning January 1, 2012. The agreement provides for base compensation, annual bonus, benefits, vacation and reimbursements. Under this agreement, the base compensation of the Company’s CEO is $100,000 per annum which has been accrued for the years ended December 13, 2015 and 2014. In mid-year 2016 the Company commenced payroll and is paying the CEO for current wages in this manner. During the year ended December 31, 2016, $18,974 in accrued compensation was paid. Accrued compensation in the amount of $30,000 was converted to shares of common stock during 2015. In August 2015, MLM acquired a trademark from the son of the Company’s President for $20,000 due 90 days from the date of acquisition. During the quarter ended June 30, 2016, the Company issued 3,400 shares of Preferred Series B stock as settlement on this liability. Due to the uncertainty of future cash flows from the trademark management has deemed it to be impaired and recorded an impairment expense of $20,000 at September 30, 2015. In August 2015, subsequent to the date the Company acquired MLM, MLM purchased $50,000 in inventory from the son of the Company’s President. The inventory consisted of 20 hand-held laser devices. During the quarter-ended March 31, 2016, 10,000 shares of Series B Preferred stock were issued in settlement of this liability. As more fully described in Note 1-Intangible Asset-Licensing Agreement, on March 8th 2016 (with an effective date of October 1, 2015) the Company entered into a Licensing Agreement with a Florida Corporation (Licensor) that is owned by a related party. The Company issued 25,000 shares of Series B Preferred stock to the Licensor as partial consideration for the Licensing agreement plus a $150,000 promissory note to the Licensor for the balance of the consideration. During the quarter-ended March 31, 2016, 3,400 shares of Series B Preferred stock were converted into 1,700,000 shares of common stock in accordance with the terms of the Series B Preferred stock. During the quarter ended March 31, 2017, 18,100 shares of Series B preferred stock was converted in 9,050,000 shares of common stock in accordance with the terms of the Series B Preferred stock.

Basis of Reporting - Going Conc

Basis of Reporting - Going Concern	3 Months Ended
	Mar. 31, 2017
Basis of Reporting - Going Concern [Abstract]
BASIS OF REPORTING - GOING CONCERN	Note 11. BASIS OF REPORTING - GOING CONCERN The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred losses from inception of approximately $2,948,991 which, among other factors, raises substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon management’s plans to raise additional capital from the sale of stock and to receive additional financing and to commence sales of it’s flagship product and create revenue. The accompanying financial statements do not include any adjustments that might be required should the Company be unable to continue as a going concern.

Stock Compensation - Equity Inc

Stock Compensation - Equity Incentive Plan	3 Months Ended
	Mar. 31, 2017
Stock Compensation - Equity Incentive Plan [Abstract]
STOCK COMPENSATION - EQUITY INCENTIVE PLAN	Note 12. STOCK COMPENSATION - EQUITY INCENTIVE PLAN In July 2016, the Company adopted the Medifirst Solutions, Inc. 2016 Equity Incentive Plan (the “Plan”) pursuant to which the Company may grant stock options, restricted stock purchase offers and other equity-based awards up to an aggregate of 20,000,000 shares of common stock. The Plan is designed to retain directors, executives and selected employees and consultants and reward them for making contributions to the success of the Company. These objectives are accomplished by making long-term incentive awards under the Plan thereby providing Participants with a proprietary interest in the growth and performance of the Company. On December 6th, 2016 the company amended the terms of the Plan and filed an S-8 Registration Statement with the Securities and Exchange Commission (“SEC”) increasing the number of shares permitted to be issued under the Plan to 32,000,000. During the quarter ended March 31, 2017, the Company issued from the Plan a total of 27,100,000 shares of common stock to non-employees for services rendered. As of March 31, 2017 there is a balance of -0- shares available for future issuance under the Medifirst Solutions, Inc. 2016 Equity Incentive Plan.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2017
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	Note 13. SUBSEQUENT EVENTS Subsequent to the quarter ended March 31, 2017, the Company issued an aggregate of 21,000,000 shares of Common Stock for services rendered by consultants and professionals. Subsequent to the quarter ended March 31, 2017, the Company issued an aggregate 86,868,815 shares of Common Stock upon conversions of an aggregate principal amount equal to approximately $200,150 outstanding convertible promissory notes. In May 2017, the Company adopted the Medifirst Solutions, Inc. 2017 Equity Incentive Plan (the “Plan”) pursuant to which the Company may grant stock options, restricted stock purchase offers and other equity-based awards up to an aggregate of 125,000,000 shares of common stock. The Plan is designed to retain directors, executives and selected employees and consultants and reward them for making contributions to the success of the Company. These objectives are accomplished by making long-term incentive awards under the Plan thereby providing Participants with a proprietary interest in the growth and performance of the Company. As of May 19, 2017 there are 104,000,000 shares available for future issuance under the Medifirst Solutions, Inc. 2017 Equity Incentive Plan.

Nature of Operations and Summ21

Nature of Operations and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2017
Nature of Operations and Summary of Significant Accounting Policies [Abstract]
Organization	Organization Medifirst Solutions, Inc. (“MSI” or the “Company”) was incorporated in Nevada in November 2010. The Company has not generated significant sales to date. The Company intends to have a diverse product line of consumer products. Since inception, the Company has been engaged in business planning activities, including researching the industry, identifying target markets for the Company’s products, developing the Company’s models and financial forecasts, performing due diligence regarding potential geographic locations most suitable for establishing the Company’s offices and identifying future sources of capital. At the present time, the Company is building products and affiliations in and related to the cosmetic healthcare industry. In July 2016, Medifirst, in response to its Premarket Notification 510(k) submission for “The Time Machine” Series Laser, received clearance from the U.S. Food and Drug Administration (“FDA”) to market its infrared Time Machine TTML- 8102000 Laser Thermal Therapeutic Device.The Company is actively putting together a sales and distribution team to offer our lasers in the US market. Pursuant to a sale and purchase agreement dated August 19, 2015 between the Company and the Company’s president, the Company acquired 100% of the equity interests in Medical Lasers Manufacturer, Inc. (“MLM”) with the total purchase price of 20,000 shares of the Company’s common stock at $0.001 per share (or $20). The fair value of the acquired entity was $20. The transaction was considered as a business acquisition and accordingly the acquisition method of accounting has been applied. MLM had no assets at the date of the business combination. The Consolidated financial statements include the accounts of MSI and its only wholly owned subsidiary, MLM. All material intercompany balances and transactions have been eliminated in consolidation. The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional funding to operationalize the Company’s current technology.
Basis of Presentation	Basis of Presentation The unaudited interim consolidated financial statements include the accounts of Medifirst Solutions Inc. and its wholly owned subsidiary (Medical Laser Manufactures, Inc., (collectively referred to as the “Company”). All material intercompany balances and transactions have been eliminated in consolidation. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the consolidated financial position of the Company as of March 31, 2017, the consolidated results of its operations for the three-month periods ended March 31, 2016 and 2017, the consolidated change in stockholders’ equity for the three-month period ended March 31, 2017 and the consolidated cash flows for the three-month periods ended March 31, 2016 and 2017. The results of operations for the three-month period ended March 31, 2017 are not necessarily indicative of the operating results for the full year. These financial statements should be read in conjunction with the audited consolidated financial statements and related disclosures for the year ended December 31, 2016 included in the Company’s Annual Report on Form 10-K for the year then ended.
Revenue Recognition	Revenue Recognition In general, the Company records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured. The following policies reflect specific criteria for the various revenues streams of the Company: Revenue is recognized at the time the product is delivered or services are performed. Provision for sales returns are estimated based on the Company’s historical return experience. Revenue is presented net of returns.
Accounts Receivable	Accounts Receivable The Company extends credit to its customers in the normal course of business and performs ongoing credit evaluations of its customers, maintaining an allowance for potential credit losses. Accounts receivable is reported net of the allowance for doubtful accounts. The allowance is based on management’s estimate of the amount of receivables that will actually be collected. The Company has not recorded an allowance for doubtful accounts as of March 31, 2017 or December 31, 2016.
Inventory	Inventory Inventory consists of finished goods and is stated at the lower of cost (first-in, first-out) or market value. Finished goods inventory includes hand held laser devices and their carrying cases.
Equipment	Equipment Equipment, consisting of computer equipment, is stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets, of five years.
Long-Lived Assets	Long-Lived Assets The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds the estimated future cash flows, an impairment loss will be recorded by the amount the carrying value exceeds the fair value of the asset. In August 2015, the Company’s wholly-owned subsidiary MLM, acquired a trademark for $20,000. Due to the uncertainty of future cash flows from the trademark, management has deemed it to be impaired and recorded an impairment expense of $20,000 in 2015.
Intangible Asset- Licensing Agreement	Intangible Asset- Licensing Agreement On March 8th 2016 (with an effective date of October 1, 2015), the company, through it’s sole wholly-owned subsidiary (“Licensee”), entered into a Product and Know-How License Agreement (“Agreement”) with a Florida Corporation (“Licensor”) which is owned by a related party - the son of the Company’s CEO. The license provides with respect to the Technology, Licensor hereby grants to Licensee an irrevocable, nontransferable, royalty-bearing license, with a right of sublicense (the “License”), throughout the Territory in the Field of Use, whether or not under the Licensed Patent, to: - use or submit or deliver the Technology and/or any Product to any regulatory body throughout the Territory for purposes of obtaining approval to make, Sell, o+A568ffer for Sale, import, export and distribute the Technology or Products; and - use or copy the Technology and/or any Product; and - market, make, have made, Sell, offer for Sale, import and distribute Products; and - sublicense the Technology; and - prepare, or have prepared on its behalf, modifications, enhancements and/or derivative works of the Technology. In connection with the license granted, Licensor hereby grants to Licensee a license to the Licensed Patents, whether now existing or hereafter acquired. The consideration for the licensing agreement consisted of the issuance of 25,000 Series B Preferred stock shares to the Licensor (at par) plus a $150,000 promissory note issued by the Company to the licensor. The promissory note is payable 18 months from the date of issuance and bears interest at the rate of 10% per annum. The last part of the consideration in this license agreement is the royalty payments which have not taken effect yet since they are based on sales for which the company has had only minimum thus far. The licensing agreement is for a ten year period effective from October 1, 2015. The cost of the licensing agreement is being amortized over it’s ten-year period and charged to income on a straight-line basis.
Debt Issues Costs and Debt Discount	Debt Issues Costs and Debt Discount The Company may pay debt issue costs, and record debt discounts in connection with raising funds through the issuance of convertible debt. These costs are amortized over the life of the debt to interest expense. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts are immediately expensed. Beginning in 2015, the Company adopted ASU 2015-03: Simplifying the Presentation of Debt Issuance Costs and has reflected the deferred financing costs as a direct reduction of the related debt (See table included in Note 5 to Consolidated Financial Statements).
Original Issue Discount	Original Issue Discount For certain convertible debt issued, the Company provides the debt holder with an original issue discount. The original issue discount is recorded to debt discount, reducing the face amount of the note and is amortized to interest expense over the life of the debt.
Derivative Liabilities	Derivative Liabilities Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes. The Company assessed its securities for purposes of determining the proper accounting treatment and valuation as set forth in the Statement of Financial Accounting Standard ASC 820–10–35–37 Fair Value in Financial Instruments Accounting for Derivative Instruments and Hedging Activities In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments. Once the derivative liabilities are determined, they are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the condensed consolidated balance sheets and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.
Financial Instruments	Financial Instruments The carrying amounts reported in the balance sheets for cash, accounts receivable, accounts payable, and other accrued liabilities approximate their fair values.
Segment Information	Segment Information The Company follows Accounting Standards Codification (“ASC”) 280, “Segment Reporting”. The Company currently operates in a single segment and will evaluate additional segment disclosure requirements as it expands its operations.
Net Income (Loss) Per Common Share	Net Income (Loss) Per Common Share The Company calculates net income (loss) per share based on the authoritative guidance. Basic earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares and dilutive common stock equivalents outstanding. During periods in which the Company incurs losses, common stock equivalents, if any, are not considered, as their effect would be anti-dilutive.
Income Taxes	Income Taxes The Company utilizes the accrual method of accounting for income taxes. Under the accrual method, deferred tax assets and liabilities are determined based on the differences between the financial reporting basis and the tax basis of the assets and liabilities, and are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. An allowance against deferred tax assets is recognized, when it is more likely than not, that such tax benefits will not be realized. The Company recognizes the financial statement benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in an examination. For tax positions meeting a “more-likely-than-not” threshold, the amount recognized in the financial statements is the benefit expected to be realized upon settlement with the tax authority. For tax positions not meeting the threshold, no financial statement benefit is recognized. The Company recognizes interest and penalties, if any, related to uncertain tax positions in income tax expense. The Company did not have any unrecognized tax benefits as of March 31, 2017, and does not expect this to change significantly over the next 12 months.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for equity instruments issued to employees in accordance with ASC 718, Compensation - Stock Compensation. ASC 718 requires all share-based compensation payments to be recognized in the financial statements based on the fair value on the issuance date. Equity instruments granted to non-employees are accounted for in accordance with ASC 505, Equity. The final measurement date for the fair value of equity instruments with performance criteria is the date that each performance commitment for such equity instrument is satisfied or there is a significant disincentive for non-performance.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At March 31, 2017 and December 31, 2016, the Company had cash equivalents of $101,768 and $165,017 respectively.
Recent Pronouncements	Recent Pronouncements In May 2014, FASB and IASB issued a new joint revenue recognition standard that supersedes nearly all GAAP guidance on revenue recognition. The core principle of the standard is that revenue recognition should depict the transfer of goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The new standard is effective for the Company to annual reporting periods beginning after December 15, 2017 (that is, a public organization is required to apply the new revenue standard beginning in the first interim period within the year of adoption). Additionally, the Board decided to permit public organizations to adopt the new revenue standard early, but not before the original public organization effective date (that is, annual periods beginning after December 15, 2016). A public organization should apply the new revenue standard to all interim reporting periods within the year of adoption. The Company has evaluated the impact of this ASU on the consolidated financial statements and has determined, at this time, the ASU’s implementation would not have a material impact on revenue recognition. See below - Accounting Standards Update 2016-10 - Revenue from Contracts with Customers (Topic 606) Identifying Performance Obligations and Licensing. On January 05, 2016, the FASB completed its Classification and Measurement of Financial Instruments project by issuing ASU No. 2016-01, Financial Instruments—Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The new guidance improves certain aspects of recognition, measurement, presentation and disclosure of financial instruments. For public business entities, the new guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company does not believe the impact of its pending adoption of this ASU on the Company’s consolidated financial statements will be material. In November 2015, FASB issued ASU 2015-17 - Income Taxes (Topic 740) Balance Sheet Classification of Deferred Taxes which simplifies the presentation of deferred income taxes. For public business entities, the amendments in this Update are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company does not believe the impact of its pending adoption of this ASU on the Company’s consolidated financial statements will be material. In March 2016, the FASB issued Accounting Standards Update 2016-09 Compensation—Stock Compensation (Topic 718) Improvements to Employee Share-Based Payment Accounting. The Board is issuing this Update as part of its Simplification Initiative. The objective of the Simplification Initiative is to identify, evaluate, and improve areas of generally accepted accounting principles (GAAP) for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided to users of financial statements. The areas for simplification in this Update were identified through outreach for the Simplification Initiative, pre-agenda research for the Private Company Council, and the August 2014 Post-Implementation Review Report on FASB Statement No. 123(R), Share-Based Payment. The Company is currently evaluating the impact of this ASU on the consolidated financial statements. In April 2016, the FASB issued Accounting Standards Update 2016-10 - Revenue from Contracts with Customers (Topic 606) Identifying Performance Obligations and Licensing. The core principle of the guidance in Topic 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps: 1. Identify the contract(s) with a customer. 2. Identify the performance obligations in the contract. 3. Determine the transaction price. 4. Allocate the transaction price to the performance obligations in the contract. 5. Recognize revenue when (or as) the entity satisfies a performance obligation. The amendments in this Update do not change the core principle of the guidance in Topic 606. Rather, the amendments in this Update clarify the following two aspects of Topic 606: identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas. The Company is currently evaluating the impact of this ASU on the consolidated financial statements.

Property, Plant and Equipment22

Property, Plant and Equipment (Net) (Tables)	3 Months Ended
	Mar. 31, 2017
Property, Plant and Equipment (Net) [Abstract]
Summary of equipment recorded at cost	March 31, 2017 December 31, Computer equipment $ 8,956 $ 8,956 Less: accumulated depreciation (7,245 ) (7,085 ) $ 1,711 $ 1,871

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2017
Short-term Debt [Line Items]
Schedule of derivative liabilities	Remaining Original Deferred Total 3/31/2017 Principal Issue Derivative Financing Convertible Derivative Debt Amount Discount Discount Costs Notes Payable Liability Note Payable - BS $ 125 $ 125 Note Payable - SF 60 60 Note Payable - SD 15,000 15,000 Note Payable - NW 715 715 Note Payable - MC #2 1,300 1,300 Convertible Note Payable - CB (5%) - - 1,358 Convertible Note Payable - LGC (8%) BEN 50,000 50,000 82,788 Convertible Note Payable - LGC (8%) BEN 46,803 46,803 76,566 Convertible Note Payable - LGC (9%) 50,000 50,000 81,797 Convertible Notes Payable- SO (8%) 25,452 (446 ) (6,893 ) (410 ) 17,703 41,481 Convertible Notes Payable- BBCG (9%) 157,895 (5,234 ) (155,738 ) (3,077 ) 220,833 $ 347,350 $ (5,680 ) $ (162,631 ) $ (410 ) $ 178,628 $ 504,823
Notes converted $110 [Member]
Short-term Debt [Line Items]
Schedule of convertible note conversion detail	Date of Conversion Principal Amount Converted Conversion Rate Shares Received June 2013 $ 70 $ 0.0001 700,000 August 2013 $ 40 $ 0.0001 400,000
New note holder converted an additional $90 [Member]
Short-term Debt [Line Items]
Schedule of convertible note conversion detail	Date of Conversion Principal Amount Converted Conversion Rate Shares Received November 2013 $ 40 $ 0.0001 400,000 December 2013 $ 50 $ 0.0001 500,000
New note holder converted an additional $90 one [Member]
Short-term Debt [Line Items]
Schedule of convertible note conversion detail	Date of Conversion Principal Amount Converted Conversion Rate Shares Received March 2014 $ 50 $ 0.0001 500,000 April 2014 $ 40 $ 0.0001 400,000
Note converted $1,010 [Member]
Short-term Debt [Line Items]
Schedule of convertible note conversion detail	Date of Conversion Principal Amount Converted Conversion Rate Shares Received December 2012 $ 150 $ 0.001 $ 150,000 January 2013 $ 660 $ 0.001 $ 660,000 March 2013 $ 200 $ 0.001 $ 200,000

Derivatives and Fair Value In24

Derivatives and Fair Value Instruments (Tables)	3 Months Ended
	Mar. 31, 2017
Derivatives and Fair Value Instruments [Abstract]
Summary of projected annual volatility for each valuation period	12/31/2016 154% 1/23/2017 152% 1/10/2017 159% 3/6/2017 165% 1/17/2017 149% 3/26/2017 168% 1/19/2017 171% 3/31/2017 174%
Summary of derivative liabilities on convertible notes payable	Convertible Note Derivative Treatment Date Maturity Date Principal Note Original Derivative Valuation Derivative Valuation December 31, 2017 Quarter Ended March 31, 2017 Issuances Quarter Ended March 31, 2017 Conversions Quarter Ended March 31, 2017 Mark-to- Market Derivative Valuation March 31, 2017 8% Convertible Note Payable- issued 5/2/2016 10/1/2016 5/2/2017 $ 57,750 $ 58,355 $ 58,355 $ (34,680 ) $ 17,806 $ 41,481 5 % Convertible Note- Payable - issued 6/12/2015 4/12/2016 1/7/2017 35,863 37,827 918 440 $ 1,358 9% Convertible Notes Payable- issued 10/01/2016 3/26/2017 3/27/2018 157,895 56,956 162,463 58,370 $ 220,833 8% Convertible Notes Payable- issued January 7, 2016 1/7/2016 1/7/2017 105,000 87,287 21,395 (136,759 ) 115,364 $ - 8% Convertible Notes Payable- issued January 7, 2016 1/7/2016 1/7/2017 50,000 15,803 15,803 66,985 $ 82,788 8% Convertible Notes Payable- issued March 7, 2016 3/7/2016 3/7/2017 50,000 87,538 36,449 45,348 $ 81,797 8% Convertible Notes Payable- issued March 7, 2016 3/7/2016 1/7/2017 46,803 82,115 15,894 60,672 $ 76,566 $ 503,311 $ 425,881 $ 148,814 $ 162,463 $ (171,439 ) $ 364,985 $ 504,823

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2017
Commitments and Contingencies [Abstract]
Schedule of agreements with consultants for ongoing services for commitments	Commitment Term Consultant - FDA requirements and compliance $2,000 per month 12 Months Consultant - capital formation and market services Various equity percentage issuances of restricted stock for fundings 6 Months Consultant - tradeshow attendance, strategy and collaboration, coordination regarding FDA compliance, manufacturing operations, sales and marketing, other related services $10,000 per month (payable quarterly in cash or common stock from the 2016 Equity Incentive Plan) 12 Months

Income Taxes (Tables)

Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2017
Income Taxes [Abstract]
Schedule of statutory federal and state income tax rates to the loss before income taxes	December 31, December 31, Statutory federal income tax rate 34 % 34 % State income taxes, net of federal taxes 9 % 9 % Valuation allowance (43 )% (43 )% Effective income tax rate 0 % 0 %

Related Party Transactions (Tab

Related Party Transactions (Tables)	3 Months Ended
	Mar. 31, 2017
Related Party Transactions [Abstract]
Summary of owed amounts to related parties	March 31, December 31, 2017 2016 Due to Related Party $ 8,921 $ 8,921 Due to officer/stockholder 16,630 10,555 Due to other stockholders 17,200 5,975 Total Related Party Obligations $ 42,751 $ 25,451

Nature of Operations and Summ28

Nature of Operations and Summary of Significant Accounting Policies (Details)	1 Months Ended			3 Months Ended	12 Months Ended
	Sep. 30, 2015USD ($)	Aug. 31, 2015USD ($)	Aug. 19, 2015USD ($)$ / sharesshares	Mar. 31, 2017USD ($)shares	Dec. 31, 2016USD ($)Segment	Dec. 31, 2015USD ($)	Mar. 31, 2016USD ($)	Feb. 29, 2016USD ($)	Dec. 31, 2012
Nature of Operations and Summary of Significant Accounting Policies (Textual)
Impairment loss-inventory
Cash equivalents				$ 101,768	$ 165,017	$ 156,958	$ 203,353
Number of operating segment | Segment					1
Estimated useful lives of the assets				Five years.
Impairment of trademark	$ 20,000
Impairment expense		$ 20,000
Equity method investment, ownership percentage			100.00%	4.99%
Fair value of acquired entity			$ 20
Total purchase price, per share | $ / shares			$ 0.001
Total purchase price | shares			20,000
Allowance for doubtful accounts
Cost of licensing agreement is being amortized term period				10 years
Series B Preferred Stock [Member]
Nature of Operations and Summary of Significant Accounting Policies (Textual)
Interest rate					10.00%
Issuance of series B preferred shares as part consideration for license agreement, shares | shares				25,000
Promissory Note [Member]
Nature of Operations and Summary of Significant Accounting Policies (Textual)
Interest rate								6.00%	10.00%
Promissory notes, description				The promissory note is payable 18 months from the date of issuance and bears interest at the rate of 10% per annum.
Promissory note issued by company				$ 150,000				$ 7,000

Property, Plant and Equipment29

Property, Plant and Equipment (Net) (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Property, Plant and Equipment (Net) [Abstract]
Computer equipment	$ 8,956	$ 8,956
Less: accumulated depreciation	(7,245)	(7,085)
Property, plant and equipment, net	$ 1,711	$ 1,871

Property, Plant and Equipment30

Property, Plant and Equipment (Net) (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Property Plant and Equipment (Net) (Textual)
Depreciation expense	$ 159	$ 346

Due to Related Party (Details)

Due to Related Party (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Due to Related Party (Textual)
Due to related party	$ 8,921	$ 8,921

Loans Payable - Stockholders (D

Loans Payable - Stockholders (Details) - USD ($)	Jan. 07, 2016	Feb. 28, 2017	Dec. 31, 2012	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2016	Feb. 29, 2016	Apr. 30, 2014
Loans Payable - Stockholders (Textual)
Stockholder of Company advance				$ 0	$ 0
Loan				$ 16,630				$ 8,955
Maturity date	Jan. 7, 2017
Principal amount converted	$ 105,000
Shares issued on conversion of convertible notes				82,730,976
Loan balance				$ 100				100
Stockholder [Member]
Loans Payable - Stockholders (Textual)
Shareholder indebted amount				$ 1,000				$ 1,500
Interest rate				26.70%
Maturity date				Jan. 1, 2014
Investor and noteholder [Member]
Loans Payable - Stockholders (Textual)
Principal amount converted		$ 500
Shares issued on conversion of convertible notes		5,000,000
Promissory note [Member]
Loans Payable - Stockholders (Textual)
Shareholder indebted amount			$ 5,000
Interest rate			10.00%						6.00%
Maturity date			Jun. 2, 2013
Conversion price per share										$ 0.0001
Principal amount converted						$ 2,400	$ 2,500
Shares issued on conversion of convertible notes						2,400,000	2,500,000
Promissory note issued by company				$ 150,000					$ 7,000

Convertible Notes Payable (Deta

Convertible Notes Payable (Details) - USD ($)	Jan. 07, 2016	Mar. 31, 2017
Summary of convertible note conversion detail
Principal Amount Converted	$ 105,000
Shares Received		82,730,976
June 2013 [Member] | Notes converted $110 [Member]
Summary of convertible note conversion detail
Principal Amount Converted		$ 70
Conversion Rate		$ 0.0001
Shares Received		700,000
August 2013 [Member] | Notes converted $110 [Member]
Summary of convertible note conversion detail
Principal Amount Converted		$ 40
Conversion Rate		$ 0.0001
Shares Received		400,000

Convertible Notes Payable (De34

Convertible Notes Payable (Details 1) - USD ($)	Jan. 07, 2016	Mar. 31, 2017
Summary of convertible note conversion detail
Principal Amount Converted	$ 105,000
Shares Received		82,730,976
November 2013 [Member] | New note holder converted an additional $90 [Member]
Summary of convertible note conversion detail
Principal Amount Converted		$ 40
Conversion Rate		$ 0.0001
Shares Received		400,000
December 2013 [Member] | New note holder converted an additional $90 [Member]
Summary of convertible note conversion detail
Principal Amount Converted		$ 50
Conversion Rate		$ 0.0001
Shares Received		500,000

Convertible Notes Payable (De35

Convertible Notes Payable (Details 2) - USD ($)	Jan. 07, 2016	Mar. 31, 2017
Summary of convertible note conversion detail
Principal Amount Converted	$ 105,000
Shares Received		82,730,976
March 2014 [Member] | Converted note additional 90 one [Member]
Summary of convertible note conversion detail
Principal Amount Converted		$ 50
Conversion Rate		$ 0.0001
Shares Received		500,000
April 2014 [Member] | Converted note additional 90 one [Member]
Summary of convertible note conversion detail
Principal Amount Converted		$ 40
Conversion Rate		$ 0.0001
Shares Received		400,000

Convertible Notes Payable (De36

Convertible Notes Payable (Details 3) - USD ($)	Jan. 07, 2016	Mar. 31, 2017
Summary of convertible note conversion detail
Principal Amount Converted	$ 105,000
Shares Received		82,730,976
December 2012 [Member] | Note converted $1,010 [Member]
Summary of convertible note conversion detail
Principal Amount Converted		$ 150
Conversion Rate		$ 0.001
Shares Received		150,000
January 2013 [Member] | Note converted $1,010 [Member]
Summary of convertible note conversion detail
Principal Amount Converted		$ 660
Conversion Rate		$ 0.001
Shares Received		660,000
March 2013 [Member] | Note converted $1,010 [Member]
Summary of convertible note conversion detail
Principal Amount Converted		$ 200
Conversion Rate		$ 0.001
Shares Received		200,000

Convertible Notes Payable (De37

Convertible Notes Payable (Details 4) - USD ($)	Mar. 31, 2017	Dec. 31, 2016	Oct. 11, 2016
Short-term Debt [Line Items]
Original Issue Discount	$ (5,680)
Derivative Discount	(162,631)
Deferred Financing Costs	(410)
Total Convertible Notes Payable	178,628	$ 391,653
Derivative Liability	504,823	$ 144,792
Note Payable - BS [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	125
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	125
Derivative Liability
Note Payable - SF [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	60
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	60
Derivative Liability
Note Payable - SD [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	15,000
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	15,000
Derivative Liability
Note Payable - NW [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	715
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	715
Derivative Liability
Note Payable - MC #2 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	1,300
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	1,300
Derivative Liability
Convertible Note Payable - CB (5%) [Member]
Short-term Debt [Line Items]
Remaining Principal Amount
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable
Derivative Liability	1,358
Convertible Note Payable - LGC (8%) BEN [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	50,000
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	50,000
Derivative Liability	82,788
Convertible Note Payable - LGC (8%) BEN 1 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	46,803
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	46,803
Derivative Liability	76,566
Convertible Note Payable - LGC (9%) [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	50,000		$ 50,000
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	50,000
Derivative Liability	81,797
Convertible Notes Payable- SO (8%) [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	25,452
Original Issue Discount	(446)
Derivative Discount	(6,893)
Deferred Financing Costs	(410)
Total Convertible Notes Payable	17,703
Derivative Liability	41,481
Convertible Notes Payable- BBCG (9%) [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	157,895
Original Issue Discount	(5,234)
Derivative Discount	(155,738)
Deferred Financing Costs
Total Convertible Notes Payable	(3,077)
Derivative Liability	$ 220,833

Convertible Notes Payable (De38

Convertible Notes Payable (Details Textual) - USD ($)	Jan. 07, 2016	Jan. 31, 2017	Aug. 31, 2016	Apr. 30, 2015	Oct. 31, 2014	Mar. 31, 2014	Dec. 31, 2013	Nov. 30, 2013	Oct. 31, 2013	Sep. 30, 2013	Aug. 31, 2013	Jul. 31, 2013	May 31, 2012	Mar. 31, 2011	Apr. 30, 2014	Mar. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2012
Convertible Notes Payable (Textual)
Principal amount transferred to Shareholders/Third party											$ 330
Amount of accrued interest transfered											$ 55
Converted shares of common stock																82,730,976
Principal amount converted	$ 105,000
Remaining principal of note																$ 1,300	$ 3,000
6% convertible notes [Member]
Convertible Notes Payable (Textual)
Maturity of convertible notes														January 2,012
Interest rate on notes														6.00%
Issued aggregate principal amount														$ 800
Notes converted $110 [Member]
Convertible Notes Payable (Textual)
Converted shares of common stock										1,000,000	50,000					1,100,000
Principal amount converted										$ 100	$ 5					$ 110
Notes converted $110 [Member] | Third Party [Member]
Convertible Notes Payable (Textual)
Converted shares of common stock										350,000
Principal amount converted										$ 35
New note holder converted an additional $90 [Member]
Convertible Notes Payable (Textual)
Converted shares of common stock						900,000	900,000	900,000							900,000
Principal amount converted						$ 90	$ 90	$ 90							$ 90
Remaining principal of note																$ 125
$240 Note [Member]
Convertible Notes Payable (Textual)
Note conversion, maximum shares issuable in percentage of issued and outstanding common stock																9.99%	9.99%
Conversion price per share												$ 0.0006				$ 0.0001	$ 0.0001
Converted shares of common stock												400,000
Principal amount converted												$ 240
Remaining principal of note																$ 60	$ 60
Issuance of common shares																39,000,529	22,562,213
$300 Note [Member]
Convertible Notes Payable (Textual)
Converted shares of common stock												300,000
Principal amount converted												$ 300
Remaining principal of note												9,690
$400 Note [Member]
Convertible Notes Payable (Textual)
Conversion price per share									$ 0.001
Converted shares of common stock									400,000
Principal amount converted									$ 400
$1,100 Note [Member]
Convertible Notes Payable (Textual)
Note conversion, maximum shares issuable in percentage of issued and outstanding common stock																	99.00%	0.001%
Conversion price per share																	$ 0.001	$ 9.99
Converted shares of common stock					1,100,000
Principal amount converted					$ 1,100
Issuance of common shares																	22,562,213	3,506,665
$25,000 Note [Member]
Convertible Notes Payable (Textual)
Maturity of convertible notes													November 2,012
Note conversion, maximum shares issuable in percentage of issued and outstanding common stock													9.99%
Retired amount of notes												$ 14,000
Interest rate on notes													6.00%						6.00%
Conversion price per share													$ 0.001
Converted shares of common stock													1,010,000
Principal amount converted													$ 1,010
Description of conversion of convertible notes													The note plus any accrued but unpaid interest were convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock.
Issued aggregate principal amount													$ 25,000
$3,000 Note [Member]
Convertible Notes Payable (Textual)
Maturity of convertible notes				October 2,015
Interest rate on notes				8.00%
Conversion price per share				$ 0.0001
Converted shares of common stock		11,000,000	3,000,000													6,000,000
Principal amount converted		$ 1,100	$ 3,000													$ 600
Remaining principal of note																$ 715	$ 715
Description of conversion of convertible notes				The holder of the note has the right to convert the principal into shares of the Company's common stock at any time 180 days after the closing date at $0.0001 per share.
Issued aggregate principal amount				$ 3,000
$4,475 Note [Member]
Convertible Notes Payable (Textual)
Principal amount transferred to Shareholders/Third party									$ 1,000
Conversion price per share											$ 0.001
Converted shares of common stock		4,190,480							700,000		700,000
Principal amount converted									$ 700		$ 700
Remaining principal of note		$ 2,075									$ 4,475

Convertible Notes Payable (De39

Convertible Notes Payable (Details Textual 1) - USD ($)	May 02, 2016	Jan. 07, 2016	Oct. 08, 2015	Aug. 31, 2015	Jul. 31, 2015	Mar. 31, 2017	Dec. 31, 2016	Jun. 12, 2015
Convertible Notes Payable (Textual)
Maturity date		Jan. 7, 2017
Remaining principal of note						$ 1,300	$ 3,000
Original issue, discount						$ (5,680)
8% Convertible Notes Payable [Member]
Convertible Notes Payable (Textual)
Convertible notes payable, principal amount	$ 60,000		$ 31,000	$ 38,000	$ 59,000
Interest rate on notes	8.00%		8.00%	8.00%	8.00%
Maturity date	May 2, 2017		Oct. 8, 2016	Mar. 31, 2016	Mar. 31, 2016
Conversion date, description	Beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company's common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion.		The note holder has the right at any time to convert any part or all of the outstanding unpaid principal balance into shares of the Company's common stock at the discounted rate of 58% of the lowest market trading price during the 20 days prior to and including the conversion date.	Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date.	Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date.
Original issue, discount			$ 1,500					$ 100,000

Convertible Notes Payable (De40

Convertible Notes Payable (Details Textual 2)

Oct. 11, 2016USD ($)

May 02, 2016USD ($)

Jan. 13, 2016USD ($)TradingDay

Jan. 07, 2016USD ($)Segment$ / shares

Oct. 15, 2015USD ($)

Oct. 08, 2015USD ($)

Sep. 27, 2016USD ($)

Aug. 31, 2015USD ($)

Jul. 31, 2015USD ($)

Jun. 30, 2015USD ($)

Mar. 31, 2017USD ($)shares

Mar. 31, 2016USD ($)

Dec. 31, 2016USD ($)

May 11, 2016USD ($)

Jul. 31, 2016USD ($)

Jun. 30, 2016USD ($)

Jun. 15, 2016USD ($)

May 31, 2016USD ($)

Mar. 15, 2016USD ($)

Dec. 31, 2015USD ($)

Jun. 25, 2015

Jun. 12, 2015USD ($)

Convertible Notes Payable (Textual)

Loss on extinguishment of debt

Maturity date

Jan. 7, 2017

Convertible notes payable converted into common stock | shares

82,730,976

Sale of convertible redeemable principal amount

$ 46,803

$ 50,000

$ 100,000

Original issue, discount

$ (5,680)

Beneficial ownership interest rate

9.99%

Convertible notes payable

178,628

$ 391,653

Remaining principal of note

1,300

3,000

Principal amount converted

$ 105,000

Convertible Notes Payable-LG (9%) [Member]

Convertible Notes Payable (Textual)

Convertible notes payable, principal amount

$ 50,000

50,000

Interest rate on notes

9.00%

8.00%

Maturity date

Mar. 27, 2018

Original issue, discount

Convertible notes payable

50,000

Remaining principal of note

0

0

Principal amount converted

$ 100,000

Convertible Notes Payable- BBCG (9%) [Member]

Convertible Notes Payable (Textual)

Convertible notes payable, principal amount

$ 46,803

Convertible Notes Payable-LGC (8%) BEN [Member]

Convertible Notes Payable (Textual)

Convertible notes payable, principal amount

$ 50,000

Interest rate on notes

8.00%

Maturity date

Jan. 7, 2017

Proceeds from discount on legal fees

$ 75,697

collateralized secured promissory note

$ 50,000

Beneficial ownership interest rate

9.99%

Common stock conversion of trading days | TradingDay

20

Conversion price, description

Conversion price equal to 55% of the lowest trading price of Common Stock during the 20 trading day period prior to conversion.

Common Stock [Member]

Convertible Notes Payable (Textual)

Convertible notes payable converted into common stock | shares

62,067,838

Conversion price per share | $ / shares

$ 55

Common stock conversion of trading days | Segment

20

Remaining principal of note

$ 0

105,000

Investor [Member]

Convertible Notes Payable (Textual)

Convertible notes payable, principal amount

$ 57,750

Interest rate on notes

8.00%

Maturity date

May 2, 2017

Conversion date, description

The holder of the note is entitled, at its option beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company's common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion.

Sale of convertible redeemable principal amount

$ 251,803

Debt instrument convertible redeemable description

(i) a convertible redeemable note in principal amount of $105,000 containing an original issue discount of $20,000 (the "$105K Note"); and (ii) a convertible redeemable note in principal amount of $50,000 (the "$50K Note" and together with the $105K Note, the "Notes").

Note receivables

(46,803)

$ (50,000)

Remaining principal of note

46,803

50,000

$ 46,803

Investor [Member] | Convertible Notes Payable- BBCG (9%) [Member]

Convertible Notes Payable (Textual)

Convertible notes payable, principal amount

$ 157,895

Interest rate on notes

9.00%

Maturity date

Mar. 27, 2018

Conversion date, description

The holder of the note is entitled, at its option beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company's common stock at the price equal to 57.5% of the lowest trading price for the twenty prior trading days including the date of conversion.

Original issue debt discount

$ 7,895

Remaining principal of note

157,895

157,895

5% CONVERTIBLE NOTES PAYABLE

Convertible Notes Payable (Textual)

Convertible notes payable, principal amount

$ 35,000

$ 100,000

$ 35,000

$ 35,000

$ 35,000

Interest rate on notes

5.00%

5.00%

Maturity date

Oct. 15, 2016

Dec. 31, 2015

Conversion date, description

Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 50% of the average of the three lowest market trading prices during the 3 days immediately preceding the conversion date.

Original issue debt discount

$ 5,000

Debt discounted rate, percentage

55.00%

Sale of convertible redeemable principal amount

$ 60,000

Convertible notes payable

Remaining principal of note

$ 100,000

100,000

$ 40,000,000

Replacement note amount

50,000

Convertible Note Payable-SO-B (8%) (Original $60k) [Member]

Convertible Notes Payable (Textual)

Convertible notes payable, principal amount

$ 60,000

$ 31,000

$ 38,000

$ 59,000

Interest rate on notes

8.00%

8.00%

8.00%

8.00%

Maturity date

May 2, 2017

Oct. 8, 2016

Mar. 31, 2016

Mar. 31, 2016

Conversion date, description

Beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company's common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion.

The note holder has the right at any time to convert any part or all of the outstanding unpaid principal balance into shares of the Company's common stock at the discounted rate of 58% of the lowest market trading price during the 20 days prior to and including the conversion date.

Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date.

Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date.

Original issue, discount

$ 1,500

$ 100,000

Convertible Note Payable-SO-B (8%) (Original $60k) [Member] | Investor [Member]

Convertible Notes Payable (Textual)

Convertible notes payable converted into common stock | shares

23,489,690

Remaining principal of note

$ 25,452

$ 57,750

Principal amount converted

$ 32,298

Debenture Payable - (5%) B (Original $100K) [Member]

Convertible Notes Payable (Textual)

Convertible notes payable, principal amount

$ 100,000

Loss on extinguishment of debt

$ 4,733

$ 4,733

Interest rate on notes

5.00%

Maturity date

Dec. 31, 2015

Conversion date, description

Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 50% of the average of the three lowest market trading prices during the 3 days immediately preceding the conversion date. The remaining principal balance on the note at June 30, 2016 was $40,000 after a private sale of $60,000 in principal and deemed accrued interest on May 2, 2016 to another investor and the issuance of a replacement note by the Company

Remaining principal of note

40,000

Replacement note amount

$ 50,000

Derivatives and Fair Value In41

Derivatives and Fair Value Instruments (Details)	3 Months Ended
	Mar. 31, 2017
12/31/2016 [Member]
Projected annual volatility for each valuation period
Volatility rate	154.00%
1/10/2017 [Member]
Projected annual volatility for each valuation period
Volatility rate	159.00%
1/17/2017 [Member]
Projected annual volatility for each valuation period
Volatility rate	149.00%
1/19/2017 [Member]
Projected annual volatility for each valuation period
Volatility rate	171.00%
1/23/2017 [Member]
Projected annual volatility for each valuation period
Volatility rate	152.00%
3/6/2017 [Member]
Projected annual volatility for each valuation period
Volatility rate	165.00%
3/26/2017 [Member]
Projected annual volatility for each valuation period
Volatility rate	168.00%
3/31/2017 [Member]
Projected annual volatility for each valuation period
Volatility rate	174.00%

Derivatives and Fair Value In42

Derivatives and Fair Value Instruments (Details 1) - USD ($)	3 Months Ended
	Mar. 31, 2017	Dec. 31, 2016	Oct. 11, 2016
Summary of convertible notes payable
Original Derivative Valuation	$ 425,881
Derivative Valuation	504,823	$ 144,792
Conversions	(171,439)
Mark-to-Market	364,985
Issuances	162,463
8% Convertible Note Payable-issued 10/8/2015 [Member]
Summary of convertible notes payable
Principal Note Amount	46,803
Derivative Valuation	$ 76,566
5% Convertible Note Payable-issued 6/12/15 [Member]
Summary of convertible notes payable
Derivative Treatment Date	Apr. 12, 2016
Maturity Date	Jan. 7, 2017
Principal Note Amount
Original Derivative Valuation	37,827
Derivative Valuation	1,358
5% Convertible Note Payable-issued 6/12/15 [Member] | Quarter Ended March 31,2017 [Member]
Summary of convertible notes payable
Mark-to-Market	440
5% Convertible Note Payable-issued 6/12/15 [Member] | Quarter Ended March 31,2017 [Member]
Summary of convertible notes payable
Derivative Valuation	1,358
8% Convertible Note Payable-issued 6/25/15 [Member]
Summary of convertible notes payable
Principal Note Amount	50,000		$ 50,000
Derivative Valuation	$ 81,797
8% Convertible Notes Payable- issued January 7, 2016 [Member]
Summary of convertible notes payable
Derivative Treatment Date	Jan. 7, 2016
Maturity Date	Jan. 7, 2017
Principal Note Amount	$ 105,000
Original Derivative Valuation	87,287
Derivative Valuation		21,395
8% Convertible Notes Payable- issued January 7, 2016 [Member] | Quarter Ended March 31,2017 [Member]
Summary of convertible notes payable
Conversions	(136,759)
Mark-to-Market	115,364
8% Convertible Notes Payable- issued January 7, 2016 [Member] | Quarter Ended March 31,2017 [Member]
Summary of convertible notes payable
Derivative Valuation
8% Convertible Notes Payable- issued January 7 2016 [Member]
Summary of convertible notes payable
Derivative Treatment Date	Jan. 7, 2016
Maturity Date	Jan. 7, 2017
Principal Note Amount	$ 50,000
Original Derivative Valuation	15,803
Derivative Valuation		15,803
8% Convertible Notes Payable- issued January 7 2016 [Member] | Quarter Ended March 31,2017 [Member]
Summary of convertible notes payable
Mark-to-Market	66,985
8% Convertible Notes Payable- issued January 7 2016 [Member] | Quarter Ended March 31,2017 [Member]
Summary of convertible notes payable
Derivative Valuation	$ 82,788
8% Convertible Notes Payable-issued March 7, 2016 [Member]
Summary of convertible notes payable
Derivative Treatment Date	Mar. 7, 2016
Maturity Date	Mar. 7, 2017
Principal Note Amount	$ 50,000
Original Derivative Valuation	87,538
8% Convertible Notes Payable-issued March 7, 2016 [Member] | Quarter Ended March 31,2017 [Member]
Summary of convertible notes payable
Mark-to-Market	45,348
8% Convertible Notes Payable-issued March 7, 2016 [Member] | Quarter Ended March 31,2017 [Member]
Summary of convertible notes payable
Derivative Valuation	$ 81,797
8% Convertible Notes Payable- issued March 7 2016 [Member]
Summary of convertible notes payable
Derivative Treatment Date	Mar. 7, 2016
Maturity Date	Jan. 7, 2017
Principal Note Amount	$ 46,803
Original Derivative Valuation	82,115
Derivative Valuation		15,894
8% Convertible Notes Payable- issued March 7 2016 [Member] | Quarter Ended March 31,2017 [Member]
Summary of convertible notes payable
Mark-to-Market	60,672
8% Convertible Notes Payable- issued March 7 2016 [Member] | Quarter Ended March 31,2017 [Member]
Summary of convertible notes payable
Derivative Valuation	$ 76,566
8% Convertible Note Payable- issued 5/2/2016 [Member]
Summary of convertible notes payable
Derivative Treatment Date	Oct. 1, 2016
Maturity Date	May 2, 2017
Principal Note Amount	$ 57,750
Original Derivative Valuation	58,355
Derivative Valuation		$ 58,355
8% Convertible Note Payable- issued 5/2/2016 [Member] | Quarter Ended March 31,2017 [Member]
Summary of convertible notes payable
Conversions	(34,680)
Mark-to-Market	17,806
8% Convertible Note Payable- issued 5/2/2016 [Member] | Quarter Ended March 31,2017 [Member]
Summary of convertible notes payable
Derivative Valuation	$ 41,481
9% Convertible Notes Payable- issued 10/01/2016 [Member]
Summary of convertible notes payable
Derivative Treatment Date	Mar. 26, 2017
Maturity Date	Mar. 27, 2018
Principal Note Amount	$ 157,895
Original Derivative Valuation	56,956
9% Convertible Notes Payable- issued 10/01/2016 [Member] | Quarter Ended March 31,2017 [Member]
Summary of convertible notes payable
Mark-to-Market	58,370
Issuances	162,463
9% Convertible Notes Payable- issued 10/01/2016 [Member] | Quarter Ended March 31,2017 [Member]
Summary of convertible notes payable
Derivative Valuation	$ 220,833

Derivatives and Fair Value In43

Derivatives and Fair Value Instruments (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2017	Oct. 01, 2016	Jan. 07, 2016	Aug. 19, 2015	Jun. 25, 2015	Jun. 12, 2015
Derivatives and Fair Value Instruments (Textual)
Derivative, description	- An event of default for the Convertible Note would occur 0% of the time, increasing 1.00% per month to a maximum of 5.0%; - Alternative financing for the Convertible Note would be initially available to redeem the note 0% of the time and increase monthly by 1% to a maximum of 10%;
Monthly trading volume	$ 262,255
Description of embedded derivative	The monthly trading volume would average $262,255 and would increase at 5% per month; ownership limits conversion across LG's 6 notes based on 4.99% with shares outstanding increasing monthly by 1%.
Equity Method Investment, Ownership Percentage	4.99%			100.00%
Fair value adjustment ((income)/expense)	$ 364,985
Maximum [Member]
Derivatives and Fair Value Instruments (Textual)
Projected annual volatility	223.00%
Stock price	$ 0.0091
Variable conversion rate	58.00%
Derivatives trading preiod	20 days
Derivatives effective rate	49.73%
Minimum [Member]
Derivatives and Fair Value Instruments (Textual)
Projected annual volatility	98.00%
Stock price	$ 0.0032
Variable conversion rate	50.00%
Derivatives trading preiod	3 days
Derivatives effective rate	35.76%
5% Convertible Note Payable-issued 6/12/15 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes						5.00%
5% Convertible Note Payable-issued 6/12/15 [Member] | Fair Value, Inputs, Level 3 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes						5.00%
8% Convertible Notes Payable- issued January 7, 2016 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes			8.00%
8% Convertible Notes Payable- issued January 7, 2016 [Member] | Fair Value, Inputs, Level 3 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes			8.00%
9% Convertible Note payable-issued October 1, 2016 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes		9.00%
9% Convertible Note payable-issued October 1, 2016 [Member] | Fair Value, Inputs, Level 3 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes		9.00%
8% Convertible Note Payable-issued June 25th 2015 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes					8.00%
8% Convertible Note Payable-issued June 25th 2015 [Member] | Fair Value, Inputs, Level 3 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes					8.00%

Stockholders' Equity (Details T

Stockholders' Equity (Details Textual) - USD ($)	Apr. 15, 2016	Mar. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Stockholders' Equity (Textual)
Common stock, shares authorized		1,500,000,000	1,500,000,000
Common stock, par value		$ 0.0001	$ 0.0001
Common stock, shares outstanding		390,395,684	225,847,976
Common stock, shares issued		390,395,684	225,847,976
Convertible preferred stock description		The Series B preferred stock has no voting rights. During the quarter ended March 31, 2017, 18,100 shares of Series B preferred shares were converted into common stock in accordance with the terms of the Series B preferred stock. As of result there were 8,000 shares of Series B preferred shares outstanding at March 31, 2017. The holders of the Series B convertible preferred stock have the right to convert the same into Common Stock of the Corporation at the ratio of one (1) share of Series B Convertible Preferred for five hundred (500) shares of Common Stock.
Issuance of Series B Preferred shares as payment for inventory			$ 50,000
Common stock value		$ 39,041	$ 22,586
Consultant [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	500,000
Common stock value	$ 5,000
Monthly cash payment to consultant	$ 750
Common shares issued upon determination of its sole and absolute discretion	500,000
Common Stock [Member]
Stockholders' Equity (Textual)
Common stock, shares authorized		1,500,000,000	1,500,000,000
Common stock, par value		$ 0.0001	$ 0.0001
Common stock, shares outstanding		390,395,684	225,847,976
Common stock, shares issued		390,395,684	225,847,976
Issuance of common shares upon conversion of shares			1,700,000
Issuance of Series B Preferred shares as payment for inventory
Common stock value			$ 5,000
Converted into shares of common stock		9,050,000
March 31, 2015 One [Member]
Stockholders' Equity (Textual)
Cancellation of common shares to recapitalize company (Shares)			500,000
March 31, 2016 [Member]
Stockholders' Equity (Textual)
Common stock, shares issued		4,787,129
March 31, 2016 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.00275
March 31, 2016 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.003355
March 31, 2016 Four [Member]
Stockholders' Equity (Textual)
Common stock, shares issued		1,700,000
Stock issued during period shares issued for conversion of of notes, shares			3,400
June 30, 2016 [Member]
Stockholders' Equity (Textual)
Issuance of common shares upon conversion of shares		1,950,000
Issuance of Series B preferred shares as payment for inventory, shares		3,900
Stock issued during period shares issued for conversion of of notes, shares		10,683,804
June 30, 2016 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.0028
June 30, 2016 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.0044
June 30, 2016 One [Member]
Stockholders' Equity (Textual)
Issuance of common shares upon conversion of shares		1,100,000
Issuance of Series B preferred shares as payment for inventory, shares		2,200
June 30, 2016 Two [Member]
Stockholders' Equity (Textual)
Issuance of common shares upon conversion of shares		1,700,000
Issuance of Series B preferred shares as payment for inventory, shares		3,400
June 30, 2016 Three [Member]
Stockholders' Equity (Textual)
Issuance of common shares upon conversion of shares		4,000
Issuance of Series B preferred shares as payment for inventory, shares		20,000
June 30, 2016 Four [Member] | Consultant [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.01
Common stock issued for services, shares		500,000
Series A preferred stock [Member]
Stockholders' Equity (Textual)
Preferred stock, shares authorized		1,000,000	1,000,000
Preferred stock, par value		$ 0.0001	$ 0.0001
Preferred stock, shares issued		50,000	50,000
Preferred stock, shares outstanding		50,000	50,000
Common stock issued for services, shares			100	100
Series A preferred stock [Member] | December 31, 2015 [Member]
Stockholders' Equity (Textual)
Preferred stock, shares authorized				1,000,000
Preferred stock, par value				$ 0.0001
Preferred stock, shares issued				50,000
Preferred stock, shares outstanding				50,000
Series B Preferred Stock [Member]
Stockholders' Equity (Textual)
Preferred stock, shares authorized		50,000	50,000
Preferred stock, par value		$ 0.0001	$ 0.0001
Preferred stock, shares issued		8,000	0
Preferred stock, shares outstanding		8,000	0
Converted into shares of common stock		18,100
Series B Preferred Stock [Member] | Consultant [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares			500,000
Series B Preferred Stock [Member] | March 31, 2016 Four [Member]
Stockholders' Equity (Textual)
Issuance of series B preferred shares as part consideration for license agreement, shares		3,400
Series B Preferred Stock [Member] | March 31, 2016 Five [Member]
Stockholders' Equity (Textual)
Preferred stock, shares issued		10,000
Issuance of Series B Preferred shares as payment for inventory		$ 50,000

Stockholders' Equity (Details45

Stockholders' Equity (Details Textual 1) - $ / shares	3 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0001	$ 0.0001
September 30, 2016 [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares	39,043,730
September 30, 2016 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, per shares	$ 0.0001
September 30, 2016 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, per shares	0.0092
September 30, 2016 One [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0092
Common stock issued for services, shares	4,000,000
September 30, 2016 Two [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	13,500,000
September 30, 2016 Two [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0001
September 30, 2016 Two [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0092
December 31, 2016 [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares	78,581,563
December 31, 2016 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, per shares	$ 0.0012
December 31, 2016 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, per shares	$ 0.0054
December 31, 2016 One [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	36,900,000
December 31, 2016 One [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0012
December 31, 2016 One [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0054
March 31, 2017 [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares	43,000,000
March 31, 2017 [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0028
March 31, 2017 [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Common stock, par value	$ 0.0094
March 31, 2017 One [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares	112,497,708
March 31, 2017 One [Member] | Minimum [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, per shares	$ 0.0001
March 31, 2017 One [Member] | Maximum [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, per shares	$ 0.0028

Commitments and Contingencies46

Commitments and Contingencies (Details)	3 Months Ended
	Mar. 31, 2017
Consultant - FDA requirements and compliance
Commitments And Contingencies [Line Items]
Commitment	$2,000 per month
Term	12 months
Consultant - capital formation and market services
Commitments And Contingencies [Line Items]
Commitment	Various equity percentage issuances of restricted stock for fundings
Term	6 months
Consultant - tradeshow attendence, strategy and collaboration, cordination regarding FDA compliance, manufacturing operations, sales and marketing, other related services
Commitments And Contingencies [Line Items]
Commitment	$10,000 per month (payable quarterly in cash or common stock from the 2016 Equity Incentive Plan)
Term	12 months

Commitments and Contingencies47

Commitments and Contingencies (Details Textual) - USD ($)	Sep. 12, 2016	Mar. 31, 2017	Mar. 31, 2016
Commitments and contingencies (Texual)
Current office space rate per month		$ 1,575
Commitments description		The Company also has ready-to-go office space available to be used for meetings etc. at a nominal cost of approximately $100 per month with no commitment.
Payments for rent		$ 1,950
Rent expense		3,822	$ 2,071
Office premises cost	$ 650
Lease agreement renewal term	3 years
Office premises cost term	1 year
Stockholder [Member]
Commitments and contingencies (Texual)
Current office space rate per month		525
Payments for rent		$ 297

Income Taxes (Details)

Income Taxes (Details)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Reconciliation of income tax rate [Abstract]
Statutory federal income tax rate	34.00%	34.00%
State income taxes, net of federal taxes	9.00%	9.00%
Valuation allowance	(43.00%)	(43.00%)
Effective income tax rate	0.00%	0.00%

Income Taxes (Details Textual)

Income Taxes (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Income Taxes (Textual)
Net operating loss carryforward		$ 1,125,667
Operating loss carryforwards expiration period, description	Reduce future federal taxable income which begins to expire in the year 2030.
Federal or state tax examinations, description	The Company currently has no federal or state tax examinations in progress, nor has it had any federal or state examinations since its inception. All of the Company’s open tax years beginning in tax year 2013 are subject to federal and state tax examinations.

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Owed amount of related parties
Due to Related Party	$ 8,921	$ 8,921
Due to officer/stockholder	16,630	10,555
Due to other stockholders	17,200	5,975
Total Related Party Obligations	$ 42,751	$ 25,451

Related Party Transactions (D51

Related Party Transactions (Details Textual)	1 Months Ended		3 Months Ended			12 Months Ended
	Sep. 30, 2015USD ($)	Aug. 31, 2015USD ($)LaserDevices$ / sharesshares	Mar. 31, 2017USD ($)shares	Jun. 30, 2016shares	Mar. 31, 2016USD ($)shares	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Feb. 29, 2016USD ($)	Aug. 19, 2015USD ($)
Related Party Transactions (Textual)
Base compensation						$ 18,974	$ 30,000
Fair value of acquired entity										$ 20
Impairment expense	$ 20,000
Officer's base compensation			$ 25,000		$ 25,000
Series B Preferred Stock
Related Party Transactions (Textual)
Issuance of series B preferred shares as part consideration for license agreement, shares | shares			25,000
Issuance of common shares upon conversion of shares | shares			18,100		3,400
Converted into shares of common stock | shares			9,050,000		1,700,000
Settlement of liability | shares				3,400	10,000
Promissory Note [Member]
Related Party Transactions (Textual)
Promissory note issued by company			$ 150,000						$ 7,000
Chief Executive Officer [Member]
Related Party Transactions (Textual)
Officer's base compensation							$ 100,000	$ 100,000
Medical Lasers Manufacturer, Inc. [Member]
Related Party Transactions (Textual)
Percentage of aquisition		100.00%
Common stock shares issued for acquisition | shares		20,000
Price per share | $ / shares		$ 0.001
Fair value of acquired entity		$ 20,000
Purchase of inventory		$ 50,000
Number of hand held devices | LaserDevices		20
Acquisition of MLM, description		MLM acquired a trademark from the son of the Company's President for $20,000 due 90 days from the date of acquisition.

Basis of Reporting - Going Co52

Basis of Reporting - Going Concern (Details)	3 Months Ended
	Mar. 31, 2017USD ($)
Basis of Reporting - Going Concern (Textual)
Net losses	$ 2,948,991

Stock Compensation - Equity I53

Stock Compensation - Equity Incentive Plan (Details) - 2016 Equity Incentive Plan [Member] - shares	Dec. 06, 2016	Jul. 31, 2016	Mar. 31, 2017
Stock Compensation - Equity Incentive Plan (Textual)
Aggregate of maximum shares of common stock		20,000,000
Common stock to non-employees for services rendered			27,100,000
Issuance of common shares	32,000,000		0

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Jan. 07, 2016	May 31, 2017	Mar. 31, 2017	May 19, 2017
Subbsequent Events (Textual)
Outstanding convertible notes converted into shares amount	$ 105,000
Debt conversion convertible shares			82,730,976
Consultants and professionals [Member]
Subbsequent Events (Textual)
Common stock issued for services, shares			21,000,000
Convertible promissory note [Member]
Subbsequent Events (Textual)
Outstanding convertible notes converted into shares amount			$ 200,150
Debt conversion convertible shares			86,868,815
Subsequent Event [Member] | 2017 Equity Incentive Plan [Member]
Subbsequent Events (Textual)
Aggregate shares of common stock		125,000,000
Shares available for future issuance				104,000,000